{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:59:59Z","timestamp":1790175599844,"version":"4.1.0"},"reference-count":320,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"DOI":"10.1038\/s41392-026-03064-x","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:03:55Z","timestamp":1790168635000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Heterogeneity in cancer: molecular mechanisms and therapeutic strategies"],"prefix":"10.1038","volume":"11","author":[{"given":"Yong-Lin","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-ming","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Qiang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Wen","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8011-2405","authenticated-orcid":false,"given":"Wei-Lin","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"key":"3064_CR1","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","volume":"15","author":"I Dagogo-Jack","year":"2018","unstructured":"Dagogo-Jack, I. & Shaw, A. T. Tumour heterogeneity and resistance to cancer therapies. Nat. Rev. Clin. Oncol. 15, 81\u201394 (2018).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"3064_CR2","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.ccell.2020.03.007","volume":"37","author":"A Marusyk","year":"2020","unstructured":"Marusyk, A., Janiszewska, M. & Polyak, K. Intratumor heterogeneity: the rosetta stone of therapy resistance. Cancer Cell 37, 471\u2013484 (2020).","journal-title":"Cancer Cell"},{"key":"3064_CR3","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/nature21356","volume":"543","author":"KM Turner","year":"2017","unstructured":"Turner, K. M. et al. Extrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneity. Nature 543, 122\u2013125 (2017).","journal-title":"Nature"},{"key":"3064_CR4","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.jhep.2017.05.014","volume":"67","author":"J Calderaro","year":"2017","unstructured":"Calderaro, J. et al. Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification. J. Hepatol. 67, 727\u2013738 (2017).","journal-title":"J. Hepatol."},{"key":"3064_CR5","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.ccell.2019.08.007","volume":"36","author":"L Ma","year":"2019","unstructured":"Ma, L. et al. Tumor cell biodiversity drives microenvironmental reprogramming in liver cancer. Cancer Cell 36, 418\u2013430.e416 (2019).","journal-title":"Cancer Cell"},{"key":"3064_CR6","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.7150\/thno.82690","volume":"13","author":"W Luo","year":"2023","unstructured":"Luo, W. Nasopharyngeal carcinoma ecology theory: cancer as multidimensional spatiotemporal \u201cunity of ecology and evolution\u201d pathological ecosystem. Theranostics 13, 1607\u20131631 (2023).","journal-title":"Theranostics"},{"key":"3064_CR7","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41568-020-0290-x","volume":"20","author":"F Mart\u00ednez-Jim\u00e9nez","year":"2020","unstructured":"Mart\u00ednez-Jim\u00e9nez, F. et al. A compendium of mutational cancer driver genes. Nat. Rev. Cancer 20, 555\u2013572 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"3064_CR8","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.immuni.2022.12.008","volume":"56","author":"J Park","year":"2023","unstructured":"Park, J., Hsueh, P. C., Li, Z. & Ho, P. C. Microenvironment-driven metabolic adaptations guiding CD8(+) T cell anti-tumor immunity. Immunity 56, 32\u201342 (2023).","journal-title":"Immunity"},{"key":"3064_CR9","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/cac2.12316","volume":"42","author":"X Chen","year":"2022","unstructured":"Chen, X. & Song, E. The theory of tumor ecosystem. Cancer Commun. (Lond.) 42, 587\u2013608 (2022).","journal-title":"Cancer Commun. (Lond.)"},{"key":"3064_CR10","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1093\/annonc\/mdq763","volume":"22","author":"VA McCormack","year":"2011","unstructured":"McCormack, V. A. & Boffetta, P. Today\u2019s lifestyles, tomorrow\u2019s cancers: trends in lifestyle risk factors for cancer in low- and middle-income countries. Ann. Oncol. 22, 2349\u20132357 (2011).","journal-title":"Ann. Oncol."},{"key":"3064_CR11","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s41568-019-0227-4","volume":"20","author":"SE Steck","year":"2020","unstructured":"Steck, S. E. & Murphy, E. A. Dietary patterns and cancer risk. Nat. Rev. Cancer 20, 125\u2013138 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"3064_CR12","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/annonc\/mdn596","volume":"20","author":"P Vineis","year":"2009","unstructured":"Vineis, P. & Xun, W. The emerging epidemic of environmental cancers in developing countries. Ann. Oncol. 20, 205\u2013212 (2009).","journal-title":"Ann. Oncol."},{"key":"3064_CR13","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.ccell.2021.08.006","volume":"39","author":"N Cullin","year":"2021","unstructured":"Cullin, N. et al. Microbiome and cancer. Cancer Cell 39, 1317\u20131341 (2021).","journal-title":"Cancer Cell"},{"key":"3064_CR14","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/s41586-022-05435-0","volume":"611","author":"JL Galeano Ni\u00f1o","year":"2022","unstructured":"Galeano Ni\u00f1o, J. L. et al. Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer. Nature 611, 810\u2013817 (2022).","journal-title":"Nature"},{"key":"3064_CR15","doi-asserted-by":"publisher","first-page":"3287","DOI":"10.1002\/cncr.34853","volume":"129","author":"LA van Tuijl","year":"2023","unstructured":"van Tuijl, L. A. et al. Depression, anxiety, and the risk of cancer: an individual participant data meta-analysis. Cancer 129, 3287\u20133299 (2023).","journal-title":"Cancer"},{"key":"3064_CR16","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1200\/JCO.23.00709","volume":"42","author":"EE Johnston","year":"2024","unstructured":"Johnston, E. E. & Rosenberg, A. R. Palliative care in adolescents and young adults with cancer. J. Clin. Oncol. 42, 755\u2013763 (2024).","journal-title":"J. Clin. Oncol."},{"key":"3064_CR17","doi-asserted-by":"publisher","first-page":"e89","DOI":"10.1017\/S2045796019000829","volume":"29","author":"L Grassi","year":"2020","unstructured":"Grassi, L. Psychiatric and psychosocial implications in cancer care: the agenda of psycho-oncology. Epidemiol. Psychiatr. Sci. 29, e89 (2020).","journal-title":"Epidemiol. Psychiatr. Sci."},{"key":"3064_CR18","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646\u2013674 (2011).","journal-title":"Cell"},{"key":"3064_CR19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan, D. Hallmarks of cancer: new dimensions. Cancer Discov. 12, 31\u201346 (2022).","journal-title":"Cancer Discov."},{"key":"3064_CR20","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser, K. E. & Joyce, J. A. The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth. Cancer Cell 41, 374\u2013403 (2023).","journal-title":"Cancer Cell"},{"key":"3064_CR21","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nature10762","volume":"481","author":"M Greaves","year":"2012","unstructured":"Greaves, M. & Maley, C. C. Clonal evolution in cancer. Nature 481, 306\u2013313 (2012).","journal-title":"Nature"},{"key":"3064_CR22","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/nrclinonc.2014.6","volume":"11","author":"HMJ Werner","year":"2014","unstructured":"Werner, H. M. J., Mills, G. B. & Ram, P. T. Cancer Systems Biology: a peek into the future of patient care? Nat. Rev. Clin. Oncol. 11, 167\u2013176 (2014).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"3064_CR23","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1158\/2159-8290.CD-24-1904","volume":"15","author":"P Gasperini","year":"2025","unstructured":"Gasperini, P. et al. Germline-somatic liaison dictates cancer subtypes via de novo steroid biosynthesis. Cancer Discov. 15, 2166\u20132184 (2025).","journal-title":"Cancer Discov."},{"key":"3064_CR24","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1158\/2159-8290.CD-16-1045","volume":"7","author":"H Carter","year":"2017","unstructured":"Carter, H. et al. Interaction landscape of inherited polymorphisms with somatic events in cancer. Cancer Discov. 7, 410\u2013423 (2017).","journal-title":"Cancer Discov."},{"key":"3064_CR25","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1001\/jama.2011.1456","volume":"306","author":"D Yang","year":"2011","unstructured":"Yang, D. et al. Association of BRCA1 and BRCA2 mutations with survival, chemotherapy sensitivity, and gene mutator phenotype in patients with ovarian cancer. JAMA 306, 1557\u20131565 (2011).","journal-title":"JAMA"},{"key":"3064_CR26","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1158\/0008-5472.CAN-25-0999","volume":"85","author":"EA Oliveira","year":"2025","unstructured":"Oliveira, E. A. et al. Epigenetic heritability of cell plasticity drives cancer drug resistance through a one-to-many genotype-to-phenotype paradigm. Cancer Res. 85, 2921\u20132938 (2025).","journal-title":"Cancer Res."},{"key":"3064_CR27","doi-asserted-by":"publisher","DOI":"10.1126\/science.add5327","volume":"380","author":"C Burdziak","year":"2023","unstructured":"Burdziak, C. et al. Epigenetic plasticity cooperates with cell-cell interactions to direct pancreatic tumorigenesis. Science 380, eadd5327 (2023).","journal-title":"Science"},{"key":"3064_CR28","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/s41586-023-06157-7","volume":"619","author":"S Papathanasiou","year":"2023","unstructured":"Papathanasiou, S. et al. Heritable transcriptional defects from aberrations of nuclear architecture. Nature 619, 184\u2013192 (2023).","journal-title":"Nature"},{"key":"3064_CR29","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/nature13556","volume":"514","author":"A Marusyk","year":"2014","unstructured":"Marusyk, A. et al. Non-cell-autonomous driving of tumour growth supports sub-clonal heterogeneity. Nature 514, 54\u201358 (2014).","journal-title":"Nature"},{"key":"3064_CR30","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/nature13187","volume":"508","author":"AS Cleary","year":"2014","unstructured":"Cleary, A. S., Leonard, T. L., Gestl, S. A. & Gunther, E. J. Tumour cell heterogeneity maintained by cooperating subclones in Wnt-driven mammary cancers. Nature 508, 113\u2013117 (2014).","journal-title":"Nature"},{"key":"3064_CR31","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/310586a0","volume":"310","author":"CJ Marshall","year":"1984","unstructured":"Marshall, C. J., Vousden, K. H. & Phillips, D. H. Activation of c-Ha-ras-1 proto-oncogene by in vitro modification with a chemical carcinogen, benzo(a)pyrene diol-epoxide. Nature 310, 586\u2013589 (1984).","journal-title":"Nature"},{"key":"3064_CR32","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1093\/oxfordjournals.annonc.a058319","volume":"3","author":"JK Cowell","year":"1992","unstructured":"Cowell, J. K. Tumour suppressor genes. Ann. Oncol. 3, 693\u2013698 (1992).","journal-title":"Ann. Oncol."},{"key":"3064_CR33","first-page":"160","volume":"44","author":"RA Weinberg","year":"1994","unstructured":"Weinberg, R. A. Oncogenes and tumor suppressor genes. CA Cancer J. Clin. 44, 160\u2013170 (1994).","journal-title":"CA Cancer J. Clin."},{"key":"3064_CR34","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1023\/A:1008209720526","volume":"8","author":"BR Voldborg","year":"1997","unstructured":"Voldborg, B. R., Damstrup, L., Spang-Thomsen, M. & Poulsen, H. S. Epidermal growth factor receptor (EGFR) and EGFR mutations, function and possible role in clinical trials. Ann. Oncol. 8, 1197\u20131206 (1997).","journal-title":"Ann. Oncol."},{"key":"3064_CR35","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.semcancer.2022.04.002","volume":"85","author":"E Levantini","year":"2022","unstructured":"Levantini, E., Maroni, G., Del Re, M. & Tenen, D. G. EGFR signaling pathway as therapeutic target in human cancers. Semin Cancer Biol. 85, 253\u2013275 (2022).","journal-title":"Semin Cancer Biol."},{"key":"3064_CR36","doi-asserted-by":"publisher","first-page":"i3","DOI":"10.1093\/annonc\/mdx702","volume":"29","author":"WH Hsu","year":"2018","unstructured":"Hsu, W. H., Yang, J. C., Mok, T. S. & Loong, H. H. Overview of current systemic management of EGFR-mutant NSCLC. Ann. Oncol. 29, i3\u2013i9 (2018).","journal-title":"Ann. Oncol."},{"key":"3064_CR37","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/s41392-021-00780-4","volume":"6","author":"L Huang","year":"2021","unstructured":"Huang, L., Guo, Z., Wang, F. & Fu, L. KRAS mutation: from undruggable to druggable in cancer. Signal Transduct. Target Ther. 6, 386 (2021).","journal-title":"Signal Transduct. Target Ther."},{"key":"3064_CR38","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.ccell.2024.04.009","volume":"42","author":"Y Liu","year":"2024","unstructured":"Liu, Y., Su, Z., Tavana, O. & Gu, W. Understanding the complexity of p53 in a new era of tumor suppression. Cancer Cell 42, 946\u2013967 (2024).","journal-title":"Cancer Cell"},{"key":"3064_CR39","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41392-023-01347-1","volume":"8","author":"H Wang","year":"2023","unstructured":"Wang, H., Guo, M., Wei, H. & Chen, Y. Targeting p53 pathways: mechanisms, structures, and advances in therapy. Signal Transduct. Target. Ther. 8, 92 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"3064_CR40","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ccell.2018.12.012","volume":"35","author":"J Kim","year":"2019","unstructured":"Kim, J. et al. Wild-type p53 promotes cancer metabolic switch by inducing PUMA-dependent suppression of oxidative phosphorylation. Cancer Cell 35, 191\u2013203.e198 (2019).","journal-title":"Cancer Cell"},{"key":"3064_CR41","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1056\/NEJMoa071825","volume":"357","author":"A Patocs","year":"2007","unstructured":"Patocs, A. et al. Breast-cancer stromal cells with TP53 mutations and nodal metastases. N. Engl. J. Med. 357, 2543\u20132551 (2007).","journal-title":"N. Engl. J. Med."},{"key":"3064_CR42","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc1048","volume":"373","author":"A Baggiolini","year":"2021","unstructured":"Baggiolini, A. et al. Developmental chromatin programs determine oncogenic competence in melanoma. Science 373, eabc1048 (2021).","journal-title":"Science"},{"key":"3064_CR43","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.annonc.2021.03.206","volume":"32","author":"A Grothey","year":"2021","unstructured":"Grothey, A., Fakih, M. & Tabernero, J. Management of BRAF-mutant metastatic colorectal cancer: a review of treatment options and evidence-based guidelines. Ann. Oncol. 32, 959\u2013967 (2021).","journal-title":"Ann. Oncol."},{"key":"3064_CR44","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.trecan.2024.06.008","volume":"10","author":"D Dibitetto","year":"2024","unstructured":"Dibitetto, D., Widmer, C. A. & Rottenberg, S. PARPi, BRCA, and gaps: controversies and future research. Trends Cancer 10, 857\u2013869 (2024).","journal-title":"Trends Cancer"},{"key":"3064_CR45","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/humupd\/dmz043","volume":"26","author":"V Turan","year":"2020","unstructured":"Turan, V. & Oktay, K. BRCA-related ATM-mediated DNA double-strand break repair and ovarian aging. Hum. Reprod. Update 26, 43\u201357 (2020).","journal-title":"Hum. Reprod. Update"},{"key":"3064_CR46","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/s41571-021-00521-0","volume":"18","author":"CJ Pirozzi","year":"2021","unstructured":"Pirozzi, C. J. & Yan, H. The implications of IDH mutations for cancer development and therapy. Nat. Rev. Clin. Oncol. 18, 645\u2013661 (2021).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"3064_CR47","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41582-024-00967-7","volume":"20","author":"R Rud\u00e0","year":"2024","unstructured":"Rud\u00e0, R. et al. IDH inhibition in gliomas: from preclinical models to clinical trials. Nat. Rev. Neurol. 20, 395\u2013407 (2024).","journal-title":"Nat. Rev. Neurol."},{"key":"3064_CR48","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1093\/neuonc\/noab105","volume":"23","author":"S Brandner","year":"2021","unstructured":"Brandner, S. et al. MGMT promoter methylation testing to predict overall survival in people with glioblastoma treated with temozolomide: a comprehensive meta-analysis based on a Cochrane Systematic Review. Neuro Oncol. 23, 1457\u20131469 (2021).","journal-title":"Neuro Oncol."},{"key":"3064_CR49","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.trecan.2020.02.010","volume":"6","author":"M Butler","year":"2020","unstructured":"Butler, M. et al. MGMT status as a clinical biomarker in glioblastoma. Trends Cancer 6, 380\u2013391 (2020).","journal-title":"Trends Cancer"},{"key":"3064_CR50","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41423-021-00634-7","volume":"18","author":"P Anderson","year":"2021","unstructured":"Anderson, P., Aptsiauri, N., Ruiz-Cabello, F. & Garrido, F. HLA class I loss in colorectal cancer: implications for immune escape and immunotherapy. Cell Mol. Immunol. 18, 556\u2013565 (2021).","journal-title":"Cell Mol. Immunol."},{"key":"3064_CR51","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/s41586-025-08721-9","volume":"640","author":"E Fiorini","year":"2025","unstructured":"Fiorini, E. et al. MYC ecDNA promotes intratumour heterogeneity and plasticity in PDAC. Nature 640, 811\u2013820 (2025).","journal-title":"Nature"},{"key":"3064_CR52","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002899","volume":"9","author":"A Hazini","year":"2021","unstructured":"Hazini, A., Fisher, K. & Seymour, L. Deregulation of HLA-I in cancer and its central importance for immunotherapy. J. Immunother. Cancer 9, e002899 (2021).","journal-title":"J. Immunother. Cancer"},{"key":"3064_CR53","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41586-020-03133-3","volume":"590","author":"RJ Quinton","year":"2021","unstructured":"Quinton, R. J. et al. Whole-genome doubling confers unique genetic vulnerabilities on tumour cells. Nature 590, 492\u2013497 (2021).","journal-title":"Nature"},{"key":"3064_CR54","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.tig.2023.08.004","volume":"39","author":"MA Vittoria","year":"2023","unstructured":"Vittoria, M. A., Quinton, R. J. & Ganem, N. J. Whole-genome doubling in tissues and tumors. Trends Genet. 39, 954\u2013967 (2023).","journal-title":"Trends Genet."},{"key":"3064_CR55","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1016\/j.cell.2021.03.009","volume":"184","author":"SC Dentro","year":"2021","unstructured":"Dentro, S. C. et al. Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes. Cell 184, 2239\u20132254.e2239 (2021).","journal-title":"Cell"},{"key":"3064_CR56","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s41568-019-0185-x","volume":"19","author":"JG Reiter","year":"2019","unstructured":"Reiter, J. G. et al. An analysis of genetic heterogeneity in untreated cancers. Nat. Rev. Cancer 19, 639\u2013650 (2019).","journal-title":"Nat. Rev. Cancer"},{"key":"3064_CR57","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1038\/s41588-021-00926-8","volume":"53","author":"KC Johnson","year":"2021","unstructured":"Johnson, K. C. et al. Single-cell multimodal glioma analyses identify epigenetic regulators of cellular plasticity and environmental stress response. Nat. Genet. 53, 1456\u20131468 (2021).","journal-title":"Nat. Genet."},{"key":"3064_CR58","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf1644","volume":"353","author":"CM Torres","year":"2016","unstructured":"Torres, C. M. et al. The linker histone H1.0 generates epigenetic and functional intratumor heterogeneity. Science 353, aaf1644 (2016).","journal-title":"Science"},{"key":"3064_CR59","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41568-024-00757-9","volume":"25","author":"M Laisn\u00e9","year":"2025","unstructured":"Laisn\u00e9, M., Lupien, M. & Vallot, C. Epigenomic heterogeneity as a source of tumour evolution. Nat. Rev. Cancer 25, 7\u201326 (2025).","journal-title":"Nat. Rev. Cancer"},{"key":"3064_CR60","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1038\/s41588-021-00927-7","volume":"53","author":"R Chaligne","year":"2021","unstructured":"Chaligne, R. et al. Epigenetic encoding, heritability and plasticity of glioma transcriptional cell states. Nat. Genet. 53, 1469\u20131479 (2021).","journal-title":"Nat. Genet."},{"key":"3064_CR61","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.tig.2022.03.010","volume":"38","author":"AL Mattei","year":"2022","unstructured":"Mattei, A. L., Bailly, N. & Meissner, A. DNA methylation: a historical perspective. Trends Genet. 38, 676\u2013707 (2022).","journal-title":"Trends Genet."},{"key":"3064_CR62","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/nrg3230","volume":"13","author":"PA Jones","year":"2012","unstructured":"Jones, P. A. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat. Rev. Genet. 13, 484\u2013492 (2012).","journal-title":"Nat. Rev. Genet."},{"key":"3064_CR63","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41571-018-0004-4","volume":"15","author":"A Koch","year":"2018","unstructured":"Koch, A. et al. Analysis of DNA methylation in cancer: location revisited. Nat. Rev. Clin. Oncol. 15, 459\u2013466 (2018).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"3064_CR64","doi-asserted-by":"publisher","first-page":"4399","DOI":"10.1158\/1078-0432.CCR-23-1295","volume":"29","author":"CJ Kinslow","year":"2023","unstructured":"Kinslow, C. J. et al. MGMT promoter methylation predicts overall survival after chemotherapy for 1p\/19q-codeleted gliomas. Clin. Cancer Res. 29, 4399\u20134407 (2023).","journal-title":"Clin. Cancer Res."},{"key":"3064_CR65","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adf6732","volume":"15","author":"Y Yamada","year":"2023","unstructured":"Yamada, Y. et al. Targeting DNA methylation and B7-H3 in RB1-deficient and neuroendocrine prostate cancer. Sci. Transl. Med. 15, eadf6732 (2023).","journal-title":"Sci. Transl. Med."},{"key":"3064_CR66","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1158\/2159-8290.CD-23-1445","volume":"14","author":"Z Liu","year":"2024","unstructured":"Liu, Z. et al. Single-cell chromatin accessibility analysis reveals the epigenetic basis and signature transcription factors for the molecular subtypes of colorectal cancers. Cancer Discov. 14, 1082\u20131105 (2024).","journal-title":"Cancer Discov."},{"key":"3064_CR67","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41580-021-00441-y","volume":"23","author":"M Shvedunova","year":"2022","unstructured":"Shvedunova, M. & Akhtar, A. Modulation of cellular processes by histone and non-histone protein acetylation. Nat. Rev. Mol. Cell Biol. 23, 329\u2013349 (2022).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"3064_CR68","doi-asserted-by":"publisher","first-page":"5691","DOI":"10.1039\/D1CS00991E","volume":"51","author":"T Bilbrough","year":"2022","unstructured":"Bilbrough, T., Piemontese, E. & Seitz, O. Dissecting the role of protein phosphorylation: a chemical biology toolbox. Chem. Soc. Rev. 51, 5691\u20135730 (2022).","journal-title":"Chem. Soc. Rev."},{"key":"3064_CR69","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41392-022-01302-6","volume":"8","author":"Y Dong","year":"2023","unstructured":"Dong, Y. et al. Phosphorylation of PHF2 by AMPK releases the repressive H3K9me2 and inhibits cancer metastasis. Signal Transduct. Target. Ther. 8, 95 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"3064_CR70","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/s41568-023-00633-y","volume":"23","author":"G Dewson","year":"2023","unstructured":"Dewson, G., Eichhorn, P. J. A. & Komander, D. Deubiquitinases in cancer. Nat. Rev. Cancer 23, 842\u2013862 (2023).","journal-title":"Nat. Rev. Cancer"},{"key":"3064_CR71","doi-asserted-by":"publisher","first-page":"4323","DOI":"10.1080\/15548627.2021.1912270","volume":"17","author":"X Li","year":"2021","unstructured":"Li, X. et al. CUL3 (cullin 3)-mediated ubiquitination and degradation of BECN1 (beclin 1) inhibit autophagy and promote tumor progression. Autophagy 17, 4323\u20134340 (2021).","journal-title":"Autophagy"},{"key":"3064_CR72","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1038\/s41586-023-06057-w","volume":"618","author":"JJ Lee","year":"2023","unstructured":"Lee, J. J. et al. ER\u03b1-associated translocations underlie oncogene amplifications in breast cancer. Nature 618, 1024\u20131032 (2023).","journal-title":"Nature"},{"key":"3064_CR73","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1182\/blood.V86.1.311.bloodjournal861311","volume":"86","author":"MA Haidar","year":"1995","unstructured":"Haidar, M. A. et al. p16INK4A and p15INK4B gene deletions in primary leukemias. Blood 86, 311\u2013315 (1995).","journal-title":"Blood"},{"key":"3064_CR74","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1016\/j.cell.2022.04.017","volume":"185","author":"D Porubsky","year":"2022","unstructured":"Porubsky, D. et al. Recurrent inversion polymorphisms in humans associate with genetic instability and genomic disorders. Cell 185, 1986\u20132005.e1926 (2022).","journal-title":"Cell"},{"key":"3064_CR75","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/nrg3123","volume":"13","author":"DJ Gordon","year":"2012","unstructured":"Gordon, D. J., Resio, B. & Pellman, D. Causes and consequences of aneuploidy in cancer. Nat. Rev. Genet. 13, 189\u2013203 (2012).","journal-title":"Nat. Rev. Genet."},{"key":"3064_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37095-7","volume":"14","author":"L Garribba","year":"2023","unstructured":"Garribba, L. et al. Short-term molecular consequences of chromosome mis-segregation for genome stability. Nat. Commun. 14, 1353 (2023).","journal-title":"Nat. Commun."},{"key":"3064_CR77","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41392-024-01767-7","volume":"9","author":"R Hosea","year":"2024","unstructured":"Hosea, R. et al. The two sides of chromosomal instability: drivers and brakes in cancer. Signal Transduct. Target. Ther. 9, 75 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"3064_CR78","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1038\/s41588-021-00951-7","volume":"53","author":"C Rosswog","year":"2021","unstructured":"Rosswog, C. et al. Chromothripsis followed by circular recombination drives oncogene amplification in human cancer. Nat. Genet. 53, 1673\u20131685 (2021).","journal-title":"Nat. Genet."},{"key":"3064_CR79","doi-asserted-by":"publisher","first-page":"4758","DOI":"10.1200\/JCO.2006.05.9238","volume":"24","author":"L Mariani","year":"2006","unstructured":"Mariani, L. et al. Loss of heterozygosity 1p36 and 19q13 is a prognostic factor for overall survival in patients with diffuse WHO grade 2 gliomas treated without chemotherapy. J. Clin. Oncol. 24, 4758\u20134763 (2006).","journal-title":"J. Clin. Oncol."},{"key":"3064_CR80","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41576-024-00761-7","volume":"26","author":"X Chen","year":"2025","unstructured":"Chen, X. et al. Chromosomal instability as a driver of cancer progression. Nat. Rev. Genet. 26, 31\u201346 (2025).","journal-title":"Nat. Rev. Genet."},{"key":"3064_CR81","doi-asserted-by":"publisher","DOI":"10.1126\/science.abg5601","volume":"376","author":"F Dietlein","year":"2022","unstructured":"Dietlein, F. et al. Genome-wide analysis of somatic noncoding mutation patterns in cancer. Science 376, eabg5601 (2022).","journal-title":"Science"},{"key":"3064_CR82","doi-asserted-by":"publisher","first-page":"18545","DOI":"10.1073\/pnas.1010978107","volume":"107","author":"I Bozic","year":"2010","unstructured":"Bozic, I. et al. Accumulation of driver and passenger mutations during tumor progression. Proc. Natl. Acad. Sci. USA 107, 18545\u201318550 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"3064_CR83","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.cell.2020.01.032","volume":"180","author":"S Kumar","year":"2020","unstructured":"Kumar, S. et al. Passenger mutations in more than 2500 cancer genomes: overall molecular functional impact and consequences. Cell 180, 915\u2013927.e916 (2020).","journal-title":"Cell"},{"key":"3064_CR84","doi-asserted-by":"publisher","first-page":"2910","DOI":"10.1073\/pnas.1213968110","volume":"110","author":"CD McFarland","year":"2013","unstructured":"McFarland, C. D. et al. Impact of deleterious passenger mutations on cancer progression. Proc. Natl. Acad. Sci. USA 110, 2910\u20132915 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"3064_CR85","doi-asserted-by":"publisher","first-page":"5771","DOI":"10.1038\/onc.2017.189","volume":"36","author":"WE Damsky","year":"2017","unstructured":"Damsky, W. E. & Bosenberg, M. Melanocytic nevi and melanoma: unraveling a complex relationship. Oncogene 36, 5771\u20135792 (2017).","journal-title":"Oncogene"},{"key":"3064_CR86","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaq1427","volume":"11","author":"FJ N\u00fa\u00f1ez","year":"2019","unstructured":"N\u00fa\u00f1ez, F. J. et al. IDH1-R132H acts as a tumor suppressor in glioma via epigenetic up-regulation of the DNA damage response. Sci. Transl. Med. 11, eaaq1427 (2019).","journal-title":"Sci. Transl. Med."},{"key":"3064_CR87","doi-asserted-by":"publisher","first-page":"4326","DOI":"10.2174\/092986710793361234","volume":"17","author":"P Wu","year":"2010","unstructured":"Wu, P. & Hu, Y. Z. PI3K\/Akt\/mTOR pathway inhibitors in cancer: a perspective on clinical progress. Curr. Med. Chem. 17, 4326\u20134341 (2010).","journal-title":"Curr. Med. Chem."},{"key":"3064_CR88","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nrclinonc.2018.28","volume":"15","author":"F Janku","year":"2018","unstructured":"Janku, F., Yap, T. A. & Meric-Bernstam, F. Targeting the PI3K pathway in cancer: are we making headway? Nat. Rev. Clin. Oncol. 15, 273\u2013291 (2018).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"3064_CR89","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1093\/neuonc\/noac064","volume":"24","author":"E Mohamed","year":"2022","unstructured":"Mohamed, E. et al. PI3K\/AKT\/mTOR signaling pathway activity in IDH-mutant diffuse glioma and clinical implications. Neuro Oncol. 24, 1471\u20131481 (2022).","journal-title":"Neuro Oncol."},{"key":"3064_CR90","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13045-020-0846-y","volume":"13","author":"F Coussy","year":"2020","unstructured":"Coussy, F. et al. Combination of PI3K and MEK inhibitors yields durable remission in PDX models of PIK3CA-mutated metaplastic breast cancers. J. Hematol. Oncol. 13, 13 (2020).","journal-title":"J. Hematol. Oncol."},{"key":"3064_CR91","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/path.5868","volume":"257","author":"D Yamamoto","year":"2022","unstructured":"Yamamoto, D. et al. Characterization of RNF43 frameshift mutations that drive Wnt ligand- and R-spondin-dependent colon cancer. J. Pathol. 257, 39\u201352 (2022).","journal-title":"J. Pathol."},{"key":"3064_CR92","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01616-7","volume":"21","author":"H Zhao","year":"2022","unstructured":"Zhao, H. et al. Wnt signaling in colorectal cancer: pathogenic role and therapeutic target. Mol. Cancer 21, 144 (2022).","journal-title":"Mol. Cancer"},{"key":"3064_CR93","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1002\/cac2.12374","volume":"42","author":"T Ge","year":"2022","unstructured":"Ge, T. et al. Crosstalk between metabolic reprogramming and epigenetics in cancer: updates on mechanisms and therapeutic opportunities. Cancer Commun. 42, 1049\u20131082 (2022).","journal-title":"Cancer Commun."},{"key":"3064_CR94","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s42255-023-00963-z","volume":"6","author":"M Demicco","year":"2024","unstructured":"Demicco, M., Liu, X.-Z., Leithner, K. & Fendt, S.-M. Metabolic heterogeneity in cancer. Nat. Metab. 6, 18\u201338 (2024).","journal-title":"Nat. Metab."},{"key":"3064_CR95","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41573-019-0032-5","volume":"18","author":"CH Patel","year":"2019","unstructured":"Patel, C. H., Leone, R. D., Horton, M. R. & Powell, J. D. Targeting metabolism to regulate immune responses in autoimmunity and cancer. Nat. Rev. Drug Discov. 18, 669\u2013688 (2019).","journal-title":"Nat. Rev. Drug Discov."},{"key":"3064_CR96","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.7150\/ijbs.89942","volume":"20","author":"F Fontana","year":"2024","unstructured":"Fontana, F., Giannitti, G., Marchesi, S. & Limonta, P. The PI3K\/Akt pathway and glucose metabolism: a dangerous liaison in cancer. Int. J. Biol. Sci. 20, 3113\u20133125 (2024).","journal-title":"Int. J. Biol. Sci."},{"key":"3064_CR97","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.cellsig.2016.01.011","volume":"28","author":"SY Hong","year":"2016","unstructured":"Hong, S. Y., Yu, F. X., Luo, Y. & Hagen, T. Oncogenic activation of the PI3K\/Akt pathway promotes cellular glucose uptake by downregulating the expression of thioredoxin-interacting protein. Cell Signal 28, 377\u2013383 (2016).","journal-title":"Cell Signal"},{"key":"3064_CR98","first-page":"1164","volume":"56","author":"M Younes","year":"1996","unstructured":"Younes, M. et al. Wide expression of the human erythrocyte glucose transporter Glut1 in human cancers. Cancer Res. 56, 1164\u20131167 (1996).","journal-title":"Cancer Res."},{"key":"3064_CR99","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15219-7","volume":"11","author":"R Commander","year":"2020","unstructured":"Commander, R. et al. Subpopulation targeting of pyruvate dehydrogenase and GLUT1 decouples metabolic heterogeneity during collective cancer cell invasion. Nat. Commun. 11, 1533 (2020).","journal-title":"Nat. Commun."},{"key":"3064_CR100","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41586-023-06537-z","volume":"623","author":"N Borcherding","year":"2023","unstructured":"Borcherding, N. & Brestoff, J. R. The power and potential of mitochondria transfer. Nature 623, 283\u2013291 (2023).","journal-title":"Nature"},{"key":"3064_CR101","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1016\/j.ccell.2023.09.003","volume":"41","author":"H Zhang","year":"2023","unstructured":"Zhang, H. et al. Systematic investigation of mitochondrial transfer between cancer cells and T cells at single-cell resolution. Cancer Cell 41, 1788\u20131802.e1710 (2023).","journal-title":"Cancer Cell"},{"key":"3064_CR102","doi-asserted-by":"publisher","first-page":"6614","DOI":"10.1016\/j.cell.2024.08.029","volume":"187","author":"JG Baldwin","year":"2024","unstructured":"Baldwin, J. G. et al. Intercellular nanotube-mediated mitochondrial transfer enhances T cell metabolic fitness and antitumor efficacy. Cell 187, 6614\u20136630.e6621 (2024).","journal-title":"Cell"},{"key":"3064_CR103","doi-asserted-by":"publisher","first-page":"103579","DOI":"10.1016\/j.autrev.2024.103579","volume":"23","author":"C Chen","year":"2024","unstructured":"Chen, C., Han, P. & Qing, Y. Metabolic heterogeneity in tumor microenvironment\u2014a novel landmark for immunotherapy. Autoimmun. Rev. 23, 103579 (2024).","journal-title":"Autoimmun. Rev."},{"key":"3064_CR104","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110609","volume":"39","author":"S Li","year":"2022","unstructured":"Li, S. et al. Metabolism drives macrophage heterogeneity in the tumor microenvironment. Cell Rep. 39, 110609 (2022).","journal-title":"Cell Rep."},{"key":"3064_CR105","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/s41568-020-0273-y","volume":"20","author":"RD Leone","year":"2020","unstructured":"Leone, R. D. & Powell, J. D. Metabolism of immune cells in cancer. Nat. Rev. Cancer 20, 516\u2013531 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"3064_CR106","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/s41576-023-00580-2","volume":"24","author":"K Vandereyken","year":"2023","unstructured":"Vandereyken, K., Sifrim, A., Thienpont, B. & Voet, T. Methods and applications for single-cell and spatial multi-omics. Nat. Rev. Genet. 24, 494\u2013515 (2023).","journal-title":"Nat. Rev. Genet."},{"key":"3064_CR107","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38360-5","volume":"14","author":"C Sun","year":"2023","unstructured":"Sun, C. et al. Spatially resolved multi-omics highlights cell-specific metabolic remodeling and interactions in gastric cancer. Nat. Commun. 14, 2692 (2023).","journal-title":"Nat. Commun."},{"key":"3064_CR108","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semcancer.2019.09.003","volume":"63","author":"TM Parker","year":"2020","unstructured":"Parker, T. M. et al. Cell competition and tumor heterogeneity. Semin Cancer Biol. 63, 1\u201310 (2020).","journal-title":"Semin Cancer Biol."},{"key":"3064_CR109","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/s41580-025-00858-9","volume":"26","author":"KJ Cheung","year":"2025","unstructured":"Cheung, K. J. & Horne-Badovinac, S. Collective migration modes in development, tissue repair and cancer. Nat. Rev. Mol. Cell Biol. 26, 741\u2013758 (2025).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"3064_CR110","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-017-0600-4","volume":"16","author":"PR Prasetyanti","year":"2017","unstructured":"Prasetyanti, P. R. & Medema, J. P. Intra-tumor heterogeneity from a cancer stem cell perspective. Mol. Cancer 16, 41 (2017).","journal-title":"Mol. Cancer"},{"key":"3064_CR111","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/s41580-022-00538-y","volume":"24","author":"SM van Neerven","year":"2023","unstructured":"van Neerven, S. M. & Vermeulen, L. Cell competition in development, homeostasis and cancer. Nat. Rev. Mol. Cell Biol. 24, 221\u2013236 (2023).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"3064_CR112","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41586-021-03525-z","volume":"594","author":"DJ Flanagan","year":"2021","unstructured":"Flanagan, D. J. et al. NOTUM from Apc-mutant cells biases clonal competition to initiate cancer. Nature 594, 430\u2013435 (2021).","journal-title":"Nature"},{"key":"3064_CR113","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/s41568-021-00376-8","volume":"21","author":"SA Vilchez Mercedes","year":"2021","unstructured":"Vilchez Mercedes, S. A. et al. Decoding leader cells in collective cancer invasion. Nat. Rev. Cancer 21, 592\u2013604 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"3064_CR114","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18794-x","volume":"11","author":"J Winkler","year":"2020","unstructured":"Winkler, J., Abisoye-Ogunniyan, A., Metcalf, K. J. & Werb, Z. Concepts of extracellular matrix remodelling in tumour progression and metastasis. Nat. Commun. 11, 5120 (2020).","journal-title":"Nat. Commun."},{"key":"3064_CR115","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41568-018-0038-z","volume":"18","author":"H Hamidi","year":"2018","unstructured":"Hamidi, H. & Ivaska, J. Every step of the way: integrins in cancer progression and metastasis. Nat. Rev. Cancer 18, 533\u2013548 (2018).","journal-title":"Nat. Rev. Cancer"},{"key":"3064_CR116","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1158\/2159-8290.CD-23-1510","volume":"14","author":"G Gargiulo","year":"2024","unstructured":"Gargiulo, G., Serresi, M. & Marine, J. C. Cell states in cancer: drivers, passengers, and trailers. Cancer Discov. 14, 610\u2013614 (2024).","journal-title":"Cancer Discov."},{"key":"3064_CR117","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nature11287","volume":"488","author":"J Chen","year":"2012","unstructured":"Chen, J. et al. A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 488, 522\u2013526 (2012).","journal-title":"Nature"},{"key":"3064_CR118","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09853-z","volume":"10","author":"A Dirkse","year":"2019","unstructured":"Dirkse, A. et al. Stem cell-associated heterogeneity in glioblastoma results from intrinsic tumor plasticity shaped by the microenvironment. Nat. Commun. 10, 1787 (2019).","journal-title":"Nat. Commun."},{"key":"3064_CR119","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1073\/pnas.1815345116","volume":"116","author":"F Bocci","year":"2019","unstructured":"Bocci, F. et al. Toward understanding cancer stem cell heterogeneity in the tumor microenvironment. Proc. Natl. Acad. Sci. USA 116, 148\u2013157 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"3064_CR120","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/cac2.12138","volume":"41","author":"G Pan","year":"2021","unstructured":"Pan, G. et al. EMT-associated microRNAs and their roles in cancer stemness and drug resistance. Cancer Commun. 41, 199\u2013217 (2021).","journal-title":"Cancer Commun."},{"key":"3064_CR121","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.semcancer.2020.12.012","volume":"75","author":"EM McCabe","year":"2021","unstructured":"McCabe, E. M. & Rasmussen, T. P. lncRNA involvement in cancer stem cell function and epithelial-mesenchymal transitions. Semin Cancer Biol. 75, 38\u201348 (2021).","journal-title":"Semin Cancer Biol."},{"key":"3064_CR122","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1016\/j.cell.2021.03.023","volume":"184","author":"E Gangoso","year":"2021","unstructured":"Gangoso, E. et al. Glioblastomas acquire myeloid-affiliated transcriptional programs via epigenetic immunoediting to elicit immune evasion. Cell 184, 2454\u20132470.e2426 (2021).","journal-title":"Cell"},{"key":"3064_CR123","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1016\/j.ccell.2024.09.010","volume":"42","author":"C Galassi","year":"2024","unstructured":"Galassi, C., Chan, T. A., Vitale, I. & Galluzzi, L. The hallmarks of cancer immune evasion. Cancer Cell 42, 1825\u20131863 (2024).","journal-title":"Cancer Cell"},{"key":"3064_CR124","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17670-y","volume":"11","author":"C Robert","year":"2020","unstructured":"Robert, C. A decade of immune-checkpoint inhibitors in cancer therapy. Nat. Commun. 11, 3801 (2020).","journal-title":"Nat. Commun."},{"key":"3064_CR125","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature25183","volume":"553","author":"RS Herbst","year":"2018","unstructured":"Herbst, R. S., Morgensztern, D. & Boshoff, C. The biology and management of non-small cell lung cancer. Nature 553, 446\u2013454 (2018).","journal-title":"Nature"},{"key":"3064_CR126","doi-asserted-by":"publisher","first-page":"107694","DOI":"10.1016\/j.pharmthera.2020.107694","volume":"219","author":"M-Y Huang","year":"2021","unstructured":"Huang, M.-Y. et al. Combination therapy with PD-1\/PD-L1 blockade in non-small cell lung cancer: strategies and mechanisms. Pharm. Ther. 219, 107694 (2021).","journal-title":"Pharm. Ther."},{"key":"3064_CR127","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1056\/NEJMoa1200694","volume":"366","author":"JR Brahmer","year":"2012","unstructured":"Brahmer, J. R. et al. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N. Engl. J. Med. 366, 2455\u20132465 (2012).","journal-title":"N. Engl. J. Med."},{"key":"3064_CR128","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.ccell.2023.01.001","volume":"41","author":"X Liu","year":"2023","unstructured":"Liu, X. et al. Immune checkpoint HLA-E:CD94-NKG2A mediates evasion of circulating tumor cells from NK cell surveillance. Cancer Cell 41, 272\u2013287.e279 (2023).","journal-title":"Cancer Cell"},{"key":"3064_CR129","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.ccell.2020.09.001","volume":"38","author":"F Dammeijer","year":"2020","unstructured":"Dammeijer, F. et al. The PD-1\/PD-L1-checkpoint restrains T cell immunity in tumor-draining lymph nodes. Cancer Cell 38, 685\u2013700.e688 (2020).","journal-title":"Cancer Cell"},{"key":"3064_CR130","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.1158\/0008-5472.CAN-22-0507","volume":"82","author":"D Li","year":"2022","unstructured":"Li, D. et al. \u03b22-Microglobulin maintains glioblastoma stem cells and induces M2-like polarization of tumor-associated macrophages. Cancer Res. 82, 3321\u20133334 (2022).","journal-title":"Cancer Res."},{"key":"3064_CR131","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41392-023-01337-3","volume":"8","author":"R Zhang","year":"2023","unstructured":"Zhang, R. et al. PMN-MDSCs modulated by CCL20 from cancer cells promoted breast cancer cell stemness through CXCL2-CXCR2 pathway. Signal Transduct. Target. Ther. 8, 97 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"3064_CR132","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.trecan.2020.10.009","volume":"7","author":"J Rodrigues","year":"2021","unstructured":"Rodrigues, J., Heinrich, M. A., Teixeira, L. M. & Prakash, J. 3D in vitro model (R)evolution: unveiling tumor-stroma interactions. Trends Cancer 7, 249\u2013264 (2021).","journal-title":"Trends Cancer"},{"key":"3064_CR133","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06110-6","volume":"14","author":"Y Zhao","year":"2023","unstructured":"Zhao, Y. et al. Stromal cells in the tumor microenvironment: accomplices of tumor progression? Cell Death Dis. 14, 587 (2023).","journal-title":"Cell Death Dis."},{"key":"3064_CR134","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1124\/pharmrev.121.000349","volume":"74","author":"LGN de Almeida","year":"2022","unstructured":"de Almeida, L. G. N. et al. Matrix metalloproteinases: from molecular mechanisms to physiology, pathophysiology, and pharmacology. Pharm. Rev. 74, 712\u2013768 (2022).","journal-title":"Pharm. Rev."},{"key":"3064_CR135","doi-asserted-by":"publisher","first-page":"4975","DOI":"10.7150\/thno.55074","volume":"11","author":"X Wan","year":"2021","unstructured":"Wan, X. et al. FOSL2 promotes VEGF-independent angiogenesis by transcriptionally activating Wnt5a in breast cancer-associated fibroblasts. Theranostics 11, 4975\u20134991 (2021).","journal-title":"Theranostics"},{"key":"3064_CR136","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s13046-023-02900-0","volume":"42","author":"Z Zhang","year":"2023","unstructured":"Zhang, Z. et al. Cancer-associated fibroblasts-derived CXCL12 enhances immune escape of bladder cancer through inhibiting P62-mediated autophagic degradation of PDL1. J. Exp. Clin. Cancer Res. 42, 316 (2023).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"3064_CR137","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13046-019-1081-7","volume":"38","author":"W Zhong","year":"2019","unstructured":"Zhong, W. et al. Human bone marrow-derived mesenchymal stem cells promote the growth and drug-resistance of diffuse large B-cell lymphoma by secreting IL-6 and elevating IL-17A levels. J. Exp. Clin. Cancer Res. 38, 73 (2019).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"3064_CR138","doi-asserted-by":"publisher","first-page":"5808","DOI":"10.1158\/0008-5472.CAN-16-2524","volume":"77","author":"J Figueroa","year":"2017","unstructured":"Figueroa, J. et al. Exosomes from glioma-associated mesenchymal stem cells increase the tumorigenicity of glioma stem-like cells via transfer of miR-1587. Cancer Res. 77, 5808\u20135819 (2017).","journal-title":"Cancer Res."},{"key":"3064_CR139","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1038\/s41586-024-08087-4","volume":"634","author":"CK Mo","year":"2024","unstructured":"Mo, C. K. et al. Tumour evolution and microenvironment interactions in 2D and 3D space. Nature 634, 1178\u20131186 (2024).","journal-title":"Nature"},{"key":"3064_CR140","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1158\/2159-8290.CD-20-1274","volume":"11","author":"D Tavernari","year":"2021","unstructured":"Tavernari, D. et al. Nongenetic evolution drives lung adenocarcinoma spatial heterogeneity and progression. Cancer Discov. 11, 1490\u20131507 (2021).","journal-title":"Cancer Discov."},{"key":"3064_CR141","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01744-8","volume":"22","author":"Z Yuan","year":"2023","unstructured":"Yuan, Z. et al. Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments. Mol. Cancer 22, 48 (2023).","journal-title":"Mol. Cancer"},{"key":"3064_CR142","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13045-021-01103-4","volume":"14","author":"T Fu","year":"2021","unstructured":"Fu, T. et al. Spatial architecture of the immune microenvironment orchestrates tumor immunity and therapeutic response. J. Hematol. Oncol. 14, 98 (2021).","journal-title":"J. Hematol. Oncol."},{"key":"3064_CR143","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.it.2022.04.010","volume":"43","author":"J Zhang","year":"2022","unstructured":"Zhang, J., Huang, D., Saw, P. E. & Song, E. Turning cold tumors hot: from molecular mechanisms to clinical applications. Trends Immunol. 43, 523\u2013545 (2022).","journal-title":"Trends Immunol."},{"key":"3064_CR144","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.343","volume":"4","author":"L Wang","year":"2023","unstructured":"Wang, L. et al. Hot and cold tumors: Immunological features and the therapeutic strategies. MedComm 4, e343 (2023).","journal-title":"MedComm"},{"key":"3064_CR145","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s41392-024-01979-x","volume":"9","author":"B Wu","year":"2024","unstructured":"Wu, B. et al. Cold and hot tumors: from molecular mechanisms to targeted therapy. Signal Transduct. Target. Ther. 9, 274 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"3064_CR146","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40398-4","volume":"14","author":"A Castiglioni","year":"2023","unstructured":"Castiglioni, A. et al. Combined PD-L1\/TGF\u03b2 blockade allows expansion and differentiation of stem cell-like CD8 T cells in immune excluded tumors. Nat. Commun. 14, 4703 (2023).","journal-title":"Nat. Commun."},{"key":"3064_CR147","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.ccell.2023.01.009","volume":"41","author":"EN Arner","year":"2023","unstructured":"Arner, E. N. & Rathmell, J. C. Metabolic programming and immune suppression in the tumor microenvironment. Cancer Cell 41, 421\u2013433 (2023).","journal-title":"Cancer Cell"},{"key":"3064_CR148","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202050827","volume":"22","author":"Z Wu","year":"2021","unstructured":"Wu, Z. et al. OMA1 reprograms metabolism under hypoxia to promote colorectal cancer development. EMBO Rep. 22, e50827 (2021).","journal-title":"EMBO Rep."},{"key":"3064_CR149","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/s41581-022-00587-8","volume":"18","author":"CT Taylor","year":"2022","unstructured":"Taylor, C. T. & Scholz, C. C. The effect of HIF on metabolism and immunity. Nat. Rev. Nephrol. 18, 573\u2013587 (2022).","journal-title":"Nat. Rev. Nephrol."},{"key":"3064_CR150","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/28867","volume":"394","author":"P Carmeliet","year":"1998","unstructured":"Carmeliet, P. et al. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394, 485\u2013490 (1998).","journal-title":"Nature"},{"key":"3064_CR151","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.164968","volume":"8","author":"H Luo","year":"2023","unstructured":"Luo, H. et al. Signaling metabolite succinylacetone activates HIF-1\u03b1 and promotes angiogenesis in GSTZ1-deficient hepatocellular carcinoma. JCI Insight 8, e164968 (2023).","journal-title":"JCI Insight"},{"key":"3064_CR152","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1016\/j.ymthe.2021.02.017","volume":"29","author":"T Chen","year":"2021","unstructured":"Chen, T. et al. WDR5 facilitates EMT and metastasis of CCA by increasing HIF-1\u03b1 accumulation in Myc-dependent and independent pathways. Mol. Ther. 29, 2134\u20132150 (2021).","journal-title":"Mol. Ther."},{"key":"3064_CR153","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.cell.2019.01.021","volume":"176","author":"RS Apte","year":"2019","unstructured":"Apte, R. S., Chen, D. S. & Ferrara, N. VEGF in signaling and disease: beyond discovery and development. Cell 176, 1248\u20131264 (2019).","journal-title":"Cell"},{"key":"3064_CR154","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1161\/CIRCRESAHA.120.316851","volume":"127","author":"G Eelen","year":"2020","unstructured":"Eelen, G., Treps, L., Li, X. & Carmeliet, P. Basic and therapeutic aspects of angiogenesis updated. Circ. Res. 127, 310\u2013329 (2020).","journal-title":"Circ. Res."},{"key":"3064_CR155","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13045-022-01292-6","volume":"15","author":"Q Wu","year":"2022","unstructured":"Wu, Q. et al. Hypoxia-inducible factors: master regulators of hypoxic tumor immune escape. J. Hematol. Oncol. 15, 77 (2022).","journal-title":"J. Hematol. Oncol."},{"key":"3064_CR156","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.ade5855","volume":"15","author":"M Wang","year":"2023","unstructured":"Wang, M. et al. Therapeutic blocking of VEGF binding to neuropilin-2 diminishes PD-L1 expression to activate antitumor immunity in prostate cancer. Sci. Transl. Med. 15, eade5855 (2023).","journal-title":"Sci. Transl. Med."},{"key":"3064_CR157","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s13046-021-01961-3","volume":"40","author":"R Sharma","year":"2021","unstructured":"Sharma, R. et al. Determinants of resistance to VEGF-TKI and immune checkpoint inhibitors in metastatic renal cell carcinoma. J. Exp. Clin. Cancer Res. 40, 186 (2021).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"3064_CR158","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02165-x","volume":"23","author":"S Liu","year":"2024","unstructured":"Liu, S. et al. Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer. Mol. Cancer 23, 261 (2024).","journal-title":"Mol. Cancer"},{"key":"3064_CR159","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13045-024-01527-8","volume":"17","author":"J Lin","year":"2024","unstructured":"Lin, J., Rao, D., Zhang, M. & Gao, Q. Metabolic reprogramming in the tumor microenvironment of liver cancer. J. Hematol. Oncol. 17, 6 (2024).","journal-title":"J. Hematol. Oncol."},{"key":"3064_CR160","doi-asserted-by":"publisher","first-page":"3824","DOI":"10.1016\/j.cell.2024.06.026","volume":"187","author":"SM Fendt","year":"2024","unstructured":"Fendt, S. M. 100 years of the Warburg effect: a cancer metabolism endeavor. Cell 187, 3824\u20133828 (2024).","journal-title":"Cell"},{"key":"3064_CR161","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41577-020-0406-2","volume":"21","author":"M Certo","year":"2021","unstructured":"Certo, M. et al. Lactate modulation of immune responses in inflammatory versus tumour microenvironments. Nat. Rev. Immunol. 21, 151\u2013161 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"3064_CR162","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/j.cell.2023.01.038","volume":"186","author":"LWS Finley","year":"2023","unstructured":"Finley, L. W. S. What is cancer metabolism? Cell 186, 1670\u20131688 (2023).","journal-title":"Cell"},{"key":"3064_CR163","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01316-8","volume":"20","author":"L Xia","year":"2021","unstructured":"Xia, L. et al. The cancer metabolic reprogramming and immune response. Mol. Cancer 20, 28 (2021).","journal-title":"Mol. Cancer"},{"key":"3064_CR164","doi-asserted-by":"publisher","first-page":"217076","DOI":"10.1016\/j.canlet.2024.217076","volume":"597","author":"Y Liu","year":"2024","unstructured":"Liu, Y. et al. Metabolic reprogramming in tumor immune microenvironment: Impact on immune cell function and therapeutic implications. Cancer Lett. 597, 217076 (2024).","journal-title":"Cancer Lett."},{"key":"3064_CR165","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06306-8","volume":"23","author":"Y Zhang","year":"2025","unstructured":"Zhang, Y. et al. Mechanical forces in the tumor microenvironment: roles, pathways, and therapeutic approaches. J. Transl. Med. 23, 313 (2025).","journal-title":"J. Transl. Med."},{"key":"3064_CR166","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ceb.2021.05.006","volume":"72","author":"V Swaminathan","year":"2021","unstructured":"Swaminathan, V. & Gloerich, M. Decoding mechanical cues by molecular mechanotransduction. Curr. Opin. Cell Biol. 72, 72\u201380 (2021).","journal-title":"Curr. Opin. Cell Biol."},{"key":"3064_CR167","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/s41586-020-2612-2","volume":"584","author":"O Chaudhuri","year":"2020","unstructured":"Chaudhuri, O. et al. Effects of extracellular matrix viscoelasticity on cellular behaviour. Nature 584, 535\u2013546 (2020).","journal-title":"Nature"},{"key":"3064_CR168","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.molmed.2021.07.009","volume":"27","author":"NK Karamanos","year":"2021","unstructured":"Karamanos, N. K. et al. Extracellular matrix-based cancer targeting. Trends Mol. Med. 27, 1000\u20131013 (2021).","journal-title":"Trends Mol. Med."},{"key":"3064_CR169","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/s41580-024-00767-3","volume":"25","author":"A Naba","year":"2024","unstructured":"Naba, A. Mechanisms of assembly and remodelling of the extracellular matrix. Nat. Rev. Mol. Cell Biol. 25, 865\u2013885 (2024).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"3064_CR170","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.eml.2018.02.003","volume":"21","author":"A Malandrino","year":"2018","unstructured":"Malandrino, A., Mak, M., Kamm, R. D. & Moeendarbary, E. Complex mechanics of the heterogeneous extracellular matrix in cancer. Extrem. Mech. Lett. 21, 25\u201334 (2018).","journal-title":"Extrem. Mech. Lett."},{"key":"3064_CR171","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.actbio.2021.07.009","volume":"131","author":"C Liu","year":"2021","unstructured":"Liu, C. et al. Heterogeneous microenvironmental stiffness regulates pro-metastatic functions of breast cancer cells. Acta Biomater. 131, 326\u2013340 (2021).","journal-title":"Acta Biomater."},{"key":"3064_CR172","doi-asserted-by":"publisher","first-page":"102422","DOI":"10.1016\/j.ceb.2024.102422","volume":"90","author":"B Bareham","year":"2024","unstructured":"Bareham, B., Dibble, M. & Parsons, M. Defining and modeling dynamic spatial heterogeneity within tumor microenvironments. Curr. Opin. Cell Biol. 90, 102422 (2024).","journal-title":"Curr. Opin. Cell Biol."},{"key":"3064_CR173","doi-asserted-by":"publisher","first-page":"5287","DOI":"10.1200\/JCO.2009.23.5556","volume":"27","author":"R Roy","year":"2009","unstructured":"Roy, R., Yang, J. & Moses, M. A. Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer. J. Clin. Oncol. 27, 5287\u20135297 (2009).","journal-title":"J. Clin. Oncol."},{"key":"3064_CR174","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.semcancer.2022.06.004","volume":"86","author":"J Liu","year":"2022","unstructured":"Liu, J. et al. Targeting matrix metalloproteinases by E3 ubiquitin ligases as a way to regulate the tumor microenvironment for cancer therapy. Semin. Cancer Biol. 86, 259\u2013268 (2022).","journal-title":"Semin. Cancer Biol."},{"key":"3064_CR175","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/s41571-021-00546-5","volume":"18","author":"Y Chen","year":"2021","unstructured":"Chen, Y., McAndrews, K. M. & Kalluri, R. Clinical and therapeutic relevance of cancer-associated fibroblasts. Nat. Rev. Clin. Oncol. 18, 792\u2013804 (2021).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"3064_CR176","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41392-024-01872-7","volume":"9","author":"P Zhou","year":"2024","unstructured":"Zhou, P. et al. Engineered extracellular vesicles for targeted reprogramming of cancer-associated fibroblasts to potentiate therapy of pancreatic cancer. Signal Transduct. Target. Ther. 9, 151 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"3064_CR177","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/j.ccell.2022.11.005","volume":"40","author":"Z Ma","year":"2022","unstructured":"Ma, Z. et al. Interferon-dependent SLC14A1(+) cancer-associated fibroblasts promote cancer stemness via WNT5A in bladder cancer. Cancer Cell 40, 1550\u20131565.e1557 (2022).","journal-title":"Cancer Cell"},{"key":"3064_CR178","doi-asserted-by":"publisher","DOI":"10.1038\/s41551-016-0004","volume":"1","author":"HT Nia","year":"2016","unstructured":"Nia, H. T. et al. Solid stress and elastic energy as measures of tumour mechanopathology. Nat. Biomed. Eng. 1, 0004 (2016).","journal-title":"Nat. Biomed. Eng."},{"key":"3064_CR179","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/s41551-018-0334-7","volume":"3","author":"G Seano","year":"2019","unstructured":"Seano, G. et al. Solid stress in brain tumours causes neuronal loss and neurological dysfunction and can be reversed by lithium. Nat. Biomed. Eng. 3, 230\u2013245 (2019).","journal-title":"Nat. Biomed. Eng."},{"key":"3064_CR180","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ccr.2014.06.003","volume":"26","author":"VP Chauhan","year":"2014","unstructured":"Chauhan, V. P. et al. Compression of pancreatic tumor blood vessels by hyaluronan is caused by solid stress and not interstitial fluid pressure. Cancer Cell 26, 14\u201315 (2014).","journal-title":"Cancer Cell"},{"key":"3064_CR181","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1007\/s10439-024-03569-y","volume":"52","author":"JA Rey","year":"2024","unstructured":"Rey, J. A. et al. Heterogeneous mechanical stress and interstitial fluid flow predictions derived from DCE-MRI for Rat U251N orthotopic gliomas. Ann. Biomed. Eng. 52, 3053\u20133066 (2024).","journal-title":"Ann. Biomed. Eng."},{"key":"3064_CR182","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ceb.2018.09.002","volume":"56","author":"J Barbaz\u00e1n","year":"2019","unstructured":"Barbaz\u00e1n, J. & Vignjevic, D. M. Cancer associated fibroblasts: is the force the path to the dark side? Curr. Opin. Cell Biol. 56, 71\u201379 (2019).","journal-title":"Curr. Opin. Cell Biol."},{"key":"3064_CR183","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12155-z","volume":"10","author":"MR Zanotelli","year":"2019","unstructured":"Zanotelli, M. R. et al. Energetic costs regulated by cell mechanics and confinement are predictive of migration path during decision-making. Nat. Commun. 10, 4185 (2019).","journal-title":"Nat. Commun."},{"key":"3064_CR184","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/s41401-020-0494-3","volume":"42","author":"M Li","year":"2021","unstructured":"Li, M., Xi, N., Wang, Y. C. & Liu, L. Q. Atomic force microscopy for revealing micro\/nanoscale mechanics in tumor metastasis: from single cells to microenvironmental cues. Acta Pharm. Sin. 42, 323\u2013339 (2021).","journal-title":"Acta Pharm. Sin."},{"key":"3064_CR185","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43458-x","volume":"14","author":"A Janesick","year":"2023","unstructured":"Janesick, A. et al. High resolution mapping of the tumor microenvironment using integrated single-cell, spatial and in situ analysis. Nat. Commun. 14, 8353 (2023).","journal-title":"Nat. Commun."},{"key":"3064_CR186","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.trecan.2023.04.004","volume":"9","author":"S Zhang","year":"2023","unstructured":"Zhang, S. et al. The peritumor microenvironment: physics and immunity. Trends Cancer 9, 609\u2013623 (2023).","journal-title":"Trends Cancer"},{"key":"3064_CR187","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-55243-5","volume":"15","author":"F Wang","year":"2024","unstructured":"Wang, F. et al. Turning attention to tumor-host interface and focus on the peritumoral heterogeneity of glioblastoma. Nat. Commun. 15, 10885 (2024).","journal-title":"Nat. Commun."},{"key":"3064_CR188","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02097-6","volume":"23","author":"Z Yang","year":"2024","unstructured":"Yang, Z. et al. YTHDF2 in peritumoral hepatocytes mediates chemotherapy-induced antitumor immune responses through CX3CL1-mediated CD8(+) T cell recruitment. Mol. Cancer 23, 186 (2024).","journal-title":"Mol. Cancer"},{"key":"3064_CR189","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202208227","volume":"19","author":"SM Chin","year":"2023","unstructured":"Chin, S. M. et al. Functional graphene for peritumoral brain microenvironment modulation therapy in glioblastoma. Small 19, e2208227 (2023).","journal-title":"Small"},{"key":"3064_CR190","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05313-5","volume":"22","author":"L Wang","year":"2024","unstructured":"Wang, L. et al. Unveiling novel cell clusters and biomarkers in glioblastoma and its peritumoral microenvironment at the single-cell perspective. J. Transl. Med. 22, 551 (2024).","journal-title":"J. Transl. Med."},{"key":"3064_CR191","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-14050-z","volume":"11","author":"B Losic","year":"2020","unstructured":"Losic, B. et al. Intratumoral heterogeneity and clonal evolution in liver cancer. Nat. Commun. 11, 291 (2020).","journal-title":"Nat. Commun."},{"key":"3064_CR192","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.cell.2018.09.018","volume":"175","author":"M Angelova","year":"2018","unstructured":"Angelova, M. et al. Evolution of metastases in space and time under immune selection. Cell 175, 751\u2013765.e716 (2018).","journal-title":"Cell"},{"key":"3064_CR193","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41392-024-01937-7","volume":"9","author":"Y Wang","year":"2024","unstructured":"Wang, Y. et al. Pre-metastatic niche: formation, characteristics and therapeutic implication. Signal Transduct. Target. Ther. 9, 236 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"3064_CR194","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.breast.2014.06.009","volume":"23","author":"C Aversa","year":"2014","unstructured":"Aversa, C. et al. Metastatic breast cancer subtypes and central nervous system metastases. Breast 23, 623\u2013628 (2014).","journal-title":"Breast"},{"key":"3064_CR195","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/bjc.2014.619","volume":"112","author":"AAL Pereira","year":"2015","unstructured":"Pereira, A. A. L. et al. Association between KRAS mutation and lung metastasis in advanced colorectal cancer. Br. J. Cancer 112, 424\u2013428 (2015).","journal-title":"Br. J. Cancer"},{"key":"3064_CR196","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1200\/JCO.2015.65.7270","volume":"34","author":"S Halabi","year":"2016","unstructured":"Halabi, S. et al. Meta-analysis evaluating the impact of site of metastasis on overall survival in men with castration-resistant prostate cancer. J. Clin. Oncol. 34, 1652\u20131659 (2016).","journal-title":"J. Clin. Oncol."},{"key":"3064_CR197","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1038\/s41588-025-02204-3","volume":"57","author":"K Zhao","year":"2025","unstructured":"Zhao, K. et al. Longitudinal and multisite sampling reveals mutational and copy number evolution in tumors during metastatic dissemination. Nat. Genet. 57, 1504\u20131511 (2025).","journal-title":"Nat. Genet."},{"key":"3064_CR198","doi-asserted-by":"publisher","first-page":"107753","DOI":"10.1016\/j.pharmthera.2020.107753","volume":"221","author":"Y Xiao","year":"2021","unstructured":"Xiao, Y. & Yu, D. Tumor microenvironment as a therapeutic target in cancer. Pharm. Ther. 221, 107753 (2021).","journal-title":"Pharm. Ther."},{"key":"3064_CR199","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01800-3","volume":"22","author":"X Chu","year":"2023","unstructured":"Chu, X. et al. Co-inhibition of TIGIT and PD-1\/PD-L1 in cancer immunotherapy: mechanisms and clinical trials. Mol. Cancer 22, 93 (2023).","journal-title":"Mol. Cancer"},{"key":"3064_CR200","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01489-2","volume":"21","author":"M Yi","year":"2022","unstructured":"Yi, M. et al. Combination strategies with PD-1\/PD-L1 blockade: current advances and future directions. Mol. Cancer 21, 28 (2022).","journal-title":"Mol. Cancer"},{"key":"3064_CR201","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1007\/s00262-018-2239-4","volume":"67","author":"S Schmid","year":"2018","unstructured":"Schmid, S. et al. Organ-specific response to nivolumab in patients with non-small cell lung cancer (NSCLC). Cancer Immunol. Immunother. 67, 1825\u20131832 (2018).","journal-title":"Cancer Immunol. Immunother."},{"key":"3064_CR202","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.ccell.2023.02.018","volume":"41","author":"L Patras","year":"2023","unstructured":"Patras, L., Shaashua, L., Matei, I. & Lyden, D. Immune determinants of the pre-metastatic niche. Cancer Cell 41, 546\u2013572 (2023).","journal-title":"Cancer Cell"},{"key":"3064_CR203","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1016\/j.immuni.2022.07.001","volume":"55","author":"Z Gong","year":"2022","unstructured":"Gong, Z. et al. Lung fibroblasts facilitate pre-metastatic niche formation by remodeling the local immune microenvironment. Immunity 55, 1483\u20131500.e1489 (2022).","journal-title":"Immunity"},{"key":"3064_CR204","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1038\/s43018-024-00854-6","volume":"5","author":"KN Jackett","year":"2024","unstructured":"Jackett, K. N. et al. How the bone microenvironment shapes the pre-metastatic niche and metastasis. Nat. Cancer 5, 1800\u20131814 (2024).","journal-title":"Nat. Cancer"},{"key":"3064_CR205","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.ccell.2024.05.004","volume":"42","author":"CS McGinnis","year":"2024","unstructured":"McGinnis, C. S. et al. The temporal progression of lung immune remodeling during breast cancer metastasis. Cancer Cell 42, 1018\u20131031.e1016 (2024).","journal-title":"Cancer Cell"},{"key":"3064_CR206","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/s41586-022-04774-2","volume":"606","author":"ME Fane","year":"2022","unstructured":"Fane, M. E. et al. Stromal changes in the aged lung induce an emergence from melanoma dormancy. Nature 606, 396\u2013405 (2022).","journal-title":"Nature"},{"key":"3064_CR207","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1053\/j.gastro.2015.08.050","volume":"149","author":"DV Catenacci","year":"2015","unstructured":"Catenacci, D. V. et al. Acquisition of portal venous circulating tumor cells from patients with pancreaticobiliary cancers by endoscopic ultrasound. Gastroenterology 149, 1794\u20131803.e1794 (2015).","journal-title":"Gastroenterology"},{"key":"3064_CR208","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/s43018-024-00881-3","volume":"6","author":"JM Link","year":"2025","unstructured":"Link, J. M. et al. Ongoing replication stress tolerance and clonal T cell responses distinguish liver and lung recurrence and outcomes in pancreatic cancer. Nat. Cancer 6, 123\u2013144 (2025).","journal-title":"Nat. Cancer"},{"key":"3064_CR209","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1016\/j.cell.2021.03.011","volume":"184","author":"W Zhang","year":"2021","unstructured":"Zhang, W. et al. The bone microenvironment invigorates metastatic seeds for further dissemination. Cell 184, 2471\u20132486.e2420 (2021).","journal-title":"Cell"},{"key":"3064_CR210","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1136\/gutjnl-2020-323703","volume":"71","author":"HN Chen","year":"2022","unstructured":"Chen, H. N. et al. Genomic evolution and diverse models of systemic metastases in colorectal cancer. Gut 71, 322\u2013332 (2022).","journal-title":"Gut"},{"key":"3064_CR211","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/s41591-022-01779-2","volume":"28","author":"EM Park","year":"2022","unstructured":"Park, E. M. et al. Targeting the gut and tumor microbiota in cancer. Nat. Med. 28, 690\u2013703 (2022).","journal-title":"Nat. Med."},{"key":"3064_CR212","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1126\/science.abf0590","volume":"372","author":"RN Carmody","year":"2021","unstructured":"Carmody, R. N., Sarkar, A. & Reese, A. T. Gut microbiota through an evolutionary lens. Science 372, 462\u2013463 (2021).","journal-title":"Science"},{"key":"3064_CR213","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1038\/s42255-024-01108-6","volume":"6","author":"E Schneider","year":"2024","unstructured":"Schneider, E., O\u2019Riordan, K. J., Clarke, G. & Cryan, J. F. Feeding gut microbes to nourish the brain: unravelling the diet-microbiota-gut-brain axis. Nat. Metab. 6, 1454\u20131478 (2024).","journal-title":"Nat. Metab."},{"key":"3064_CR214","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/s41575-023-00890-0","volume":"21","author":"MR Aburto","year":"2024","unstructured":"Aburto, M. R. & Cryan, J. F. Gastrointestinal and brain barriers: unlocking gates of communication across the microbiota-gut-brain axis. Nat. Rev. Gastroenterol. Hepatol. 21, 222\u2013247 (2024).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"3064_CR215","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s13046-021-01983-x","volume":"40","author":"X Liu","year":"2021","unstructured":"Liu, X., Chen, Y., Zhang, S. & Dong, L. Gut microbiota-mediated immunomodulation in tumor. J. Exp. Clin. Cancer Res. 40, 221 (2021).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"3064_CR216","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1016\/j.cell.2024.03.021","volume":"187","author":"TW Battaglia","year":"2024","unstructured":"Battaglia, T. W. et al. A pan-cancer analysis of the microbiome in metastatic cancer. Cell 187, 2324\u20132335.e2319 (2024).","journal-title":"Cell"},{"key":"3064_CR217","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41571-023-00766-x","volume":"20","author":"CC Wong","year":"2023","unstructured":"Wong, C. C. & Yu, J. Gut microbiota in colorectal cancer development and therapy. Nat. Rev. Clin. Oncol. 20, 429\u2013452 (2023).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"3064_CR218","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202205563","volume":"10","author":"R Qu","year":"2023","unstructured":"Qu, R. et al. Role of the gut microbiota and its metabolites in tumorigenesis or development of colorectal cancer. Adv. Sci. 10, e2205563 (2023).","journal-title":"Adv. Sci."},{"key":"3064_CR219","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1158\/2159-8290.CD-24-1259","volume":"15","author":"Y Lu","year":"2025","unstructured":"Lu, Y. et al. Intrahepatic microbial heterogeneity in multifocal hepatocellular carcinoma and its association with host genomic and transcriptomic alterations. Cancer Discov. 15, 1630\u20131648 (2025).","journal-title":"Cancer Discov."},{"key":"3064_CR220","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1146\/annurev-biochem-052521-033250","volume":"92","author":"E Choi","year":"2023","unstructured":"Choi, E. & Bai, X. C. The activation mechanism of the insulin receptor: a structural perspective. Annu. Rev. Biochem. 92, 247\u2013272 (2023).","journal-title":"Annu. Rev. Biochem."},{"key":"3064_CR221","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13045-019-0778-6","volume":"12","author":"Q Wu","year":"2019","unstructured":"Wu, Q. et al. Cancer-associated adipocytes: key players in breast cancer progression. J. Hematol. Oncol. 12, 95 (2019).","journal-title":"J. Hematol. Oncol."},{"key":"3064_CR222","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/nrc.2016.71","volume":"16","author":"BJ Altman","year":"2016","unstructured":"Altman, B. J., Stine, Z. E. & Dang, C. V. From Krebs to clinic: glutamine metabolism to cancer therapy. Nat. Rev. Cancer 16, 619\u2013634 (2016).","journal-title":"Nat. Rev. Cancer"},{"key":"3064_CR223","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41586-019-1126-2","volume":"569","author":"Y Saito","year":"2019","unstructured":"Saito, Y. et al. LLGL2 rescues nutrient stress by promoting leucine uptake in ER(+) breast cancer. Nature 569, 275\u2013279 (2019).","journal-title":"Nature"},{"key":"3064_CR224","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ccell.2019.12.011","volume":"37","author":"S Sivanand","year":"2020","unstructured":"Sivanand, S. & Vander Heiden, M. G. Emerging roles for branched-chain amino acid metabolism in cancer. Cancer Cell 37, 147\u2013156 (2020).","journal-title":"Cancer Cell"},{"key":"3064_CR225","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41416-019-0650-z","volume":"122","author":"N Koundouros","year":"2020","unstructured":"Koundouros, N. & Poulogiannis, G. Reprogramming of fatty acid metabolism in cancer. Br. J. Cancer 122, 4\u201322 (2020).","journal-title":"Br. J. Cancer"},{"key":"3064_CR226","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/s41568-021-00388-4","volume":"21","author":"AJ Hoy","year":"2021","unstructured":"Hoy, A. J., Nagarajan, S. R. & Butler, L. M. Tumour fatty acid metabolism in the context of therapy resistance and obesity. Nat. Rev. Cancer 21, 753\u2013766 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"3064_CR227","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s42255-020-0174-0","volume":"2","author":"B Huang","year":"2020","unstructured":"Huang, B., Song, B. L. & Xu, C. Cholesterol metabolism in cancer: mechanisms and therapeutic opportunities. Nat. Metab. 2, 132\u2013141 (2020).","journal-title":"Nat. Metab."},{"key":"3064_CR228","doi-asserted-by":"publisher","first-page":"5477","DOI":"10.1158\/0008-5472.CAN-20-4028","volume":"81","author":"A El-Kenawi","year":"2021","unstructured":"El-Kenawi, A. et al. Macrophage-derived cholesterol contributes to therapeutic resistance in prostate cancer. Cancer Res. 81, 5477\u20135490 (2021).","journal-title":"Cancer Res."},{"key":"3064_CR229","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.immuni.2024.03.021","volume":"57","author":"J Xiao","year":"2024","unstructured":"Xiao, J. et al. 25-Hydroxycholesterol regulates lysosome AMP kinase activation and metabolic reprogramming to educate immunosuppressive macrophages. Immunity 57, 1087\u20131104.e1087 (2024).","journal-title":"Immunity"},{"key":"3064_CR230","doi-asserted-by":"publisher","first-page":"115234","DOI":"10.1016\/j.celrep.2025.115234","volume":"44","author":"AL Cote","year":"2025","unstructured":"Cote, A. L., Munger, C. J. & Ringel, A. E. Emerging insights into the impact of systemic metabolic changes on tumor-immune interactions. Cell Rep. 44, 115234 (2025).","journal-title":"Cell Rep."},{"key":"3064_CR231","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S0140-6736(21)00312-3","volume":"398","author":"AA Thai","year":"2021","unstructured":"Thai, A. A. et al. Lung cancer. Lancet 398, 535\u2013554 (2021).","journal-title":"Lancet"},{"key":"3064_CR232","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.fertnstert.2024.05.002","volume":"122","author":"MEM van der Perk","year":"2024","unstructured":"van der Perk, M. E. M. et al. Interindividual variation in ovarian reserve after gonadotoxic treatment in female childhood cancer survivors\u2014a genome-wide association study: results from PanCareLIFE. Fertil. Steril. 122, 514\u2013524 (2024).","journal-title":"Fertil. Steril."},{"key":"3064_CR233","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/s41418-022-01098-6","volume":"30","author":"G Zhang","year":"2023","unstructured":"Zhang, G. et al. Deficiency of cancer\/testis antigen gene CT55 causes male infertility in humans and mice. Cell Death Differ. 30, 500\u2013514 (2023).","journal-title":"Cell Death Differ."},{"key":"3064_CR234","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1016\/j.immuni.2023.10.008","volume":"56","author":"JP Hoffmann","year":"2023","unstructured":"Hoffmann, J. P., Liu, J. A., Seddu, K. & Klein, S. L. Sex hormone signaling and regulation of immune function. Immunity 56, 2472\u20132491 (2023).","journal-title":"Immunity"},{"key":"3064_CR235","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2020.105543","volume":"137","author":"S Li","year":"2020","unstructured":"Li, S. et al. Sex hormones and genetic variants in hormone metabolic pathways associated with the risk of colorectal cancer. Environ. Int. 137, 105543 (2020).","journal-title":"Environ. Int."},{"key":"3064_CR236","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41574-019-0194-6","volume":"15","author":"V Bernard","year":"2019","unstructured":"Bernard, V., Young, J. & Binart, N. Prolactin\u2014a pleiotropic factor in health and disease. Nat. Rev. Endocrinol. 15, 356\u2013365 (2019).","journal-title":"Nat. Rev. Endocrinol."},{"key":"3064_CR237","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/S0140-6736(23)00020-X","volume":"401","author":"DW Chen","year":"2023","unstructured":"Chen, D. W. et al. Thyroid cancer. Lancet 401, 1531\u20131544 (2023).","journal-title":"Lancet"},{"key":"3064_CR238","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1001\/jama.2023.26348","volume":"331","author":"L Boucai","year":"2024","unstructured":"Boucai, L., Zafereo, M. & Cabanillas, M. E. Thyroid cancer: a review. JAMA 331, 425\u2013435 (2024).","journal-title":"JAMA"},{"key":"3064_CR239","doi-asserted-by":"publisher","first-page":"925","DOI":"10.6004\/jnccn.2022.0040","volume":"20","author":"RI Haddad","year":"2022","unstructured":"Haddad, R. I. et al. Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. J. Natl. Compr. Canc. Netw. 20, 925\u2013951 (2022).","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"3064_CR240","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1210\/endrev\/bnac010","volume":"43","author":"S Melmed","year":"2022","unstructured":"Melmed, S. et al. Clinical biology of the pituitary adenoma. Endocr. Rev. 43, 1003\u20131037 (2022).","journal-title":"Endocr. Rev."},{"key":"3064_CR241","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41572-019-0125-9","volume":"5","author":"HL M\u00fcller","year":"2019","unstructured":"M\u00fcller, H. L. et al. Craniopharyngioma. Nat. Rev. Dis. Prim. 5, 75 (2019).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"3064_CR242","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/s41571-023-00734-5","volume":"20","author":"JM Argil\u00e9s","year":"2023","unstructured":"Argil\u00e9s, J. M., L\u00f3pez-Soriano, F. J., Stemmler, B. & Busquets, S. Cancer-associated cachexia - understanding the tumour macroenvironment and microenvironment to improve management. Nat. Rev. Clin. Oncol. 20, 250\u2013264 (2023).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"3064_CR243","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1158\/2159-8290.CD-25-0293","volume":"15","author":"K Koh","year":"2025","unstructured":"Koh, K. et al. Cancer-associated cachexia: bridging clinical findings with mechanistic insights in human studies. Cancer Discov. 15, 1543\u20131568 (2025).","journal-title":"Cancer Discov."},{"key":"3064_CR244","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1016\/j.cell.2023.03.028","volume":"186","author":"M Ferrer","year":"2023","unstructured":"Ferrer, M. et al. Cachexia: a systemic consequence of progressive, unresolved disease. Cell 186, 1824\u20131845 (2023).","journal-title":"Cell"},{"key":"3064_CR245","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41416-022-01826-2","volume":"127","author":"J McGovern","year":"2022","unstructured":"McGovern, J. et al. Cancer cachexia: a nutritional or a systemic inflammatory syndrome? Br. J. Cancer 127, 379\u2013382 (2022).","journal-title":"Br. J. Cancer"},{"key":"3064_CR246","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.immuni.2021.01.018","volume":"54","author":"V Deretic","year":"2021","unstructured":"Deretic, V. Autophagy in inflammation, infection, and immunometabolism. Immunity 54, 437\u2013453 (2021).","journal-title":"Immunity"},{"key":"3064_CR247","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41392-025-02241-8","volume":"10","author":"T Pu","year":"2025","unstructured":"Pu, T., Sun, J., Ren, G. & Li, H. Neuro-immune crosstalk in cancer: mechanisms and therapeutic implications. Signal Transduct. Target. Ther. 10, 176 (2025).","journal-title":"Signal Transduct. Target. Ther."},{"key":"3064_CR248","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/s41586-024-07469-y","volume":"630","author":"H Jin","year":"2024","unstructured":"Jin, H. et al. A body-brain circuit that regulates body inflammatory responses. Nature 630, 695\u2013703 (2024).","journal-title":"Nature"},{"key":"3064_CR249","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02246-5","volume":"24","author":"Y Zhang","year":"2025","unstructured":"Zhang, Y. et al. Hijacking of the nervous system in cancer: mechanism and therapeutic targets. Mol. Cancer 24, 44 (2025).","journal-title":"Mol. Cancer"},{"key":"3064_CR250","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s13046-024-03202-9","volume":"43","author":"Y Zheng","year":"2024","unstructured":"Zheng, Y. et al. Mechanisms of neural infiltration-mediated tumor metabolic reprogramming impacting immunotherapy efficacy in non-small cell lung cancer. J. Exp. Clin. Cancer Res. 43, 284 (2024).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"3064_CR251","doi-asserted-by":"publisher","first-page":"5877","DOI":"10.1016\/j.cell.2024.08.050","volume":"187","author":"M Sammons","year":"2024","unstructured":"Sammons, M. et al. Brain-body physiology: local, reflex, and central communication. Cell 187, 5877\u20135890 (2024).","journal-title":"Cell"},{"key":"3064_CR252","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/s41422-024-01004-4","volume":"34","author":"L Hosang","year":"2024","unstructured":"Hosang, L., Fl\u00fcgel, A. & Odoardi, F. Body-brain axis: orchestrating immune responses. Cell Res. 34, 757\u2013758 (2024).","journal-title":"Cell Res."},{"key":"3064_CR253","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/s41586-019-1563-y","volume":"573","author":"HS Venkatesh","year":"2019","unstructured":"Venkatesh, H. S. et al. Electrical and synaptic integration of glioma into neural circuits. Nature 573, 539\u2013545 (2019).","journal-title":"Nature"},{"key":"3064_CR254","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202506694","volume":"12","author":"T Wu","year":"2025","unstructured":"Wu, T. et al. Neuro-cancer interactions shape glioma intratumoral heterogeneity. Adv. Sci. 12, e06694 (2025).","journal-title":"Adv. Sci."},{"key":"3064_CR255","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/s41420-022-00928-3","volume":"8","author":"D Sigorski","year":"2022","unstructured":"Sigorski, D. & I\u017cycka-\u015awieszewska, E. Sympathetic nervous signaling dictates prostate cancer progression. Cell Death Discov. 8, 109 (2022).","journal-title":"Cell Death Discov."},{"key":"3064_CR256","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41568-019-0237-2","volume":"20","author":"AH Zahalka","year":"2020","unstructured":"Zahalka, A. H. & Frenette, P. S. Nerves in cancer. Nat. Rev. Cancer 20, 143\u2013157 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"3064_CR257","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1158\/2326-6066.CIR-20-0445","volume":"9","author":"G Qiao","year":"2021","unstructured":"Qiao, G. et al. Chronic adrenergic stress contributes to metabolic dysfunction and an exhausted phenotype in T cells in the tumor microenvironment. Cancer Immunol. Res. 9, 651\u2013664 (2021).","journal-title":"Cancer Immunol. Res."},{"key":"3064_CR258","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1158\/0008-5472.CAN-24-3173","volume":"85","author":"T Li","year":"2025","unstructured":"Li, T. et al. Cancer-associated fibroblasts foster a high-lactate microenvironment to drive perineural invasion in pancreatic cancer. Cancer Res. 85, 2199\u20132217 (2025).","journal-title":"Cancer Res."},{"key":"3064_CR259","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1002\/cac2.12188","volume":"41","author":"J Li","year":"2021","unstructured":"Li, J., Kang, R. & Tang, D. Cellular and molecular mechanisms of perineural invasion of pancreatic ductal adenocarcinoma. Cancer Commun. 41, 642\u2013660 (2021).","journal-title":"Cancer Commun."},{"key":"3064_CR260","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41420-021-00450-y","volume":"7","author":"H Wang","year":"2021","unstructured":"Wang, H. et al. Role of the nervous system in cancers: a review. Cell Death Discov. 7, 76 (2021).","journal-title":"Cell Death Discov."},{"key":"3064_CR261","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1053\/j.seminoncol.2021.09.004","volume":"48","author":"S Zhang","year":"2021","unstructured":"Zhang, S. Chemotherapy-induced peripheral neuropathy and rehabilitation: a review. Semin Oncol. 48, 193\u2013207 (2021).","journal-title":"Semin Oncol."},{"key":"3064_CR262","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1136\/bjo-2022-322854","volume":"107","author":"AR Carey","year":"2023","unstructured":"Carey, A. R., Page, B. R. & Miller, N. Radiation-induced optic neuropathy: a review. Br. J. Ophthalmol. 107, 743\u2013749 (2023).","journal-title":"Br. J. Ophthalmol."},{"key":"3064_CR263","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1158\/0008-5472.CAN-20-2793","volume":"81","author":"DA Silverman","year":"2021","unstructured":"Silverman, D. A. et al. Cancer-associated neurogenesis and nerve-cancer cross-talk. Cancer Res. 81, 1431\u20131440 (2021).","journal-title":"Cancer Res."},{"key":"3064_CR264","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/nrc3978","volume":"15","author":"SW Cole","year":"2015","unstructured":"Cole, S. W. et al. Sympathetic nervous system regulation of the tumour microenvironment. Nat. Rev. Cancer 15, 563\u2013572 (2015).","journal-title":"Nat. Rev. Cancer"},{"key":"3064_CR265","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2112840119","volume":"119","author":"H Xie","year":"2022","unstructured":"Xie, H. et al. An immune-sympathetic neuron communication axis guides adipose tissue browning in cancer-associated cachexia. Proc. Natl. Acad. Sci. USA 119, e2112840119 (2022).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"3064_CR266","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2022.188828","volume":"1877","author":"J Hu","year":"2022","unstructured":"Hu, J. et al. Crosstalk between the peripheral nervous system and breast cancer influences tumor progression. Biochim. Biophys. Acta Rev. Cancer 1877, 188828 (2022).","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"3064_CR267","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.cell.2015.10.067","volume":"163","author":"Z Zhao","year":"2015","unstructured":"Zhao, Z., Nelson, A. R., Betsholtz, C. & Zlokovic, B. V. Establishment and dysfunction of the blood-brain barrier. Cell 163, 1064\u20131078 (2015).","journal-title":"Cell"},{"key":"3064_CR268","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1038\/s41593-024-01743-y","volume":"27","author":"SJ Pfau","year":"2024","unstructured":"Pfau, S. J. et al. Characteristics of blood-brain barrier heterogeneity between brain regions revealed by profiling vascular and perivascular cells. Nat. Neurosci. 27, 1892\u20131903 (2024).","journal-title":"Nat. Neurosci."},{"key":"3064_CR269","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1161\/CIRCRESAHA.120.317473","volume":"128","author":"MA M\u00e4e","year":"2021","unstructured":"M\u00e4e, M. A. et al. Single-cell analysis of blood-brain barrier response to pericyte loss. Circ. Res. 128, e46\u2013e62 (2021).","journal-title":"Circ. Res."},{"key":"3064_CR270","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.113605","volume":"381","author":"LL Song","year":"2025","unstructured":"Song, L. L. et al. Exosomal delivery of rapamycin modulates blood-brain barrier penetration and VEGF axis in glioblastoma. J. Control Release 381, 113605 (2025).","journal-title":"J. Control Release"},{"key":"3064_CR271","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.86066","volume":"12","author":"S Parab","year":"2023","unstructured":"Parab, S. et al. Local angiogenic interplay of Vegfc\/d and Vegfa controls brain region-specific emergence of fenestrated capillaries. eLife 12, e86066 (2023).","journal-title":"eLife"},{"key":"3064_CR272","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s00018-011-0731-5","volume":"69","author":"J Yan","year":"2012","unstructured":"Yan, J., Zhang, Z. & Shi, H. HIF-1 is involved in high glucose-induced paracellular permeability of brain endothelial cells. Cell Mol. Life Sci. 69, 115\u2013128 (2012).","journal-title":"Cell Mol. Life Sci."},{"key":"3064_CR273","doi-asserted-by":"publisher","first-page":"31150","DOI":"10.1021\/acsami.3c03001","volume":"15","author":"Y Li","year":"2023","unstructured":"Li, Y. et al. Macrophage-cancer hybrid membrane-camouflaged nanoplatforms for HIF-1\u03b1 gene silencing-enhanced sonodynamic therapy of glioblastoma. ACS Appl. Mater. Interfaces 15, 31150\u201331158 (2023).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"3064_CR274","doi-asserted-by":"publisher","first-page":"e13747","DOI":"10.1111\/acel.13747","volume":"22","author":"MK Preininger","year":"2023","unstructured":"Preininger, M. K., Zaytseva, D., Lin, J. M. & Kaufer, D. Blood-brain barrier dysfunction promotes astrocyte senescence through albumin-induced TGF\u03b2 signaling activation. Aging Cell 22, e13747 (2023).","journal-title":"Aging Cell"},{"key":"3064_CR275","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s41571-021-00529-6","volume":"18","author":"PS Steeg","year":"2021","unstructured":"Steeg, P. S. The blood-tumour barrier in cancer biology and therapy. Nat. Rev. Clin. Oncol. 18, 696\u2013714 (2021).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"3064_CR276","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.1016\/j.neuron.2024.07.026","volume":"112","author":"Y Xie","year":"2024","unstructured":"Xie, Y. et al. Single-cell dissection of the human blood-brain barrier and glioma blood-tumor barrier. Neuron 112, 3089\u20133105.e3087 (2024).","journal-title":"Neuron"},{"key":"3064_CR277","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1021\/acsnano.2c10219","volume":"17","author":"J Cui","year":"2023","unstructured":"Cui, J. et al. Immune exosomes loading self-assembled nanomicelles traverse the blood-brain barrier for chemo-immunotherapy against glioblastoma. ACS Nano 17, 1464\u20131484 (2023).","journal-title":"ACS Nano"},{"key":"3064_CR278","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1158\/1078-0432.CCR-19-2034","volume":"26","author":"A Arina","year":"2020","unstructured":"Arina, A., Gutiontov, S. I. & Weichselbaum, R. R. Radiotherapy and immunotherapy for cancer: from \u201csystemic\u201d to \u201cmultisite. Clin. Cancer Res. 26, 2777\u20132782 (2020).","journal-title":"Clin. Cancer Res."},{"key":"3064_CR279","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.trecan.2021.10.003","volume":"8","author":"KB Pointer","year":"2022","unstructured":"Pointer, K. B., Pitroda, S. P. & Weichselbaum, R. R. Radiotherapy and immunotherapy: open questions and future strategies. Trends Cancer 8, 9\u201320 (2022).","journal-title":"Trends Cancer"},{"key":"3064_CR280","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1210\/endrev\/bnab002","volume":"42","author":"K Desai","year":"2021","unstructured":"Desai, K., McManus, J. M. & Sharifi, N. Hormonal therapy for prostate cancer. Endocr. Rev. 42, 354\u2013373 (2021).","journal-title":"Endocr. Rev."},{"key":"3064_CR281","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s13045-021-01141-y","volume":"14","author":"Z Weng","year":"2021","unstructured":"Weng, Z. et al. Therapeutic roles of mesenchymal stem cell-derived extracellular vesicles in cancer. J. Hematol. Oncol. 14, 136 (2021).","journal-title":"J. Hematol. Oncol."},{"key":"3064_CR282","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan4672","volume":"359","author":"CE Dunbar","year":"2018","unstructured":"Dunbar, C. E. et al. Gene therapy comes of age. Science 359, eaan4672 (2018).","journal-title":"Science"},{"key":"3064_CR283","doi-asserted-by":"publisher","first-page":"a026781","DOI":"10.1101\/cshperspect.a026781","volume":"7","author":"E Hirata","year":"2017","unstructured":"Hirata, E. & Sahai, E. Tumor microenvironment and differential responses to therapy. Cold Spring Harb. Perspect. Med. 7, a026781 (2017).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"3064_CR284","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.70012","volume":"14","author":"GYQ Han","year":"2024","unstructured":"Han, G. Y. Q. et al. Ecological and evolutionary dynamics to design and improve ovarian cancer treatment. Clin. Transl. Med. 14, e70012 (2024).","journal-title":"Clin. Transl. Med."},{"key":"3064_CR285","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1002\/ijc.30252","volume":"139","author":"HR Wardill","year":"2016","unstructured":"Wardill, H. R. et al. Cytokine-mediated blood brain barrier disruption as a conduit for cancer\/chemotherapy-associated neurotoxicity and cognitive dysfunction. Int. J. Cancer 139, 2635\u20132645 (2016).","journal-title":"Int. J. Cancer"},{"key":"3064_CR286","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/med.21977","volume":"44","author":"M Skurlova","year":"2024","unstructured":"Skurlova, M. et al. Chemobrain in blood cancers: How chemotherapeutics interfere with the brain\u2019s structure and functionality, immune system, and metabolic functions. Med. Res. Rev. 44, 5\u201322 (2024).","journal-title":"Med. Res. Rev."},{"key":"3064_CR287","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19933-0","volume":"11","author":"YH Park","year":"2020","unstructured":"Park, Y. H. et al. Chemotherapy induces dynamic immune responses in breast cancers that impact treatment outcome. Nat. Commun. 11, 6175 (2020).","journal-title":"Nat. Commun."},{"key":"3064_CR288","doi-asserted-by":"publisher","first-page":"3606","DOI":"10.1007\/s12325-020-01419-6","volume":"37","author":"RS Epstein","year":"2020","unstructured":"Epstein, R. S. et al. Patient burden and real-world management of chemotherapy-induced myelosuppression: results from an online survey of patients with solid tumors. Adv. Ther. 37, 3606\u20133618 (2020).","journal-title":"Adv. Ther."},{"key":"3064_CR289","doi-asserted-by":"publisher","first-page":"103429","DOI":"10.1016\/j.critrevonc.2021.103429","volume":"165","author":"K Jaye","year":"2021","unstructured":"Jaye, K., Li, C. G. & Bhuyan, D. J. The complex interplay of gut microbiota with the five most common cancer types: From carcinogenesis to therapeutics to prognoses. Crit. Rev. Oncol. Hematol. 165, 103429 (2021).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"3064_CR290","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-019-0679-5","volume":"7","author":"BY Hong","year":"2019","unstructured":"Hong, B. Y. et al. Chemotherapy-induced oral mucositis is associated with detrimental bacterial dysbiosis. Microbiome 7, 66 (2019).","journal-title":"Microbiome"},{"key":"3064_CR291","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04554-0","volume":"21","author":"Z Yu","year":"2023","unstructured":"Yu, Z. et al. Tissue fibrosis induced by radiotherapy: current understanding of the molecular mechanisms, diagnosis and therapeutic advances. J. Transl. Med. 21, 708 (2023).","journal-title":"J. Transl. Med."},{"key":"3064_CR292","doi-asserted-by":"publisher","first-page":"109863","DOI":"10.1016\/j.radonc.2023.109863","volume":"188","author":"Z Iyizoba-Ebozue","year":"2023","unstructured":"Iyizoba-Ebozue, Z. et al. Neurocognitive function following (chemo)radiotherapy for nasopharyngeal cancer and other head and neck cancers: a systematic review. Radiother. Oncol. 188, 109863 (2023).","journal-title":"Radiother. Oncol."},{"key":"3064_CR293","doi-asserted-by":"publisher","first-page":"e152","DOI":"10.1016\/S1470-2045(24)00656-9","volume":"26","author":"ZS Morris","year":"2025","unstructured":"Morris, Z. S. et al. Proceedings of the National Cancer Institute Workshop on combining immunotherapy with radiotherapy: challenges and opportunities for clinical translation. Lancet Oncol. 26, e152\u2013e170 (2025).","journal-title":"Lancet Oncol."},{"key":"3064_CR294","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.semcancer.2023.11.006","volume":"98","author":"C Beckers","year":"2024","unstructured":"Beckers, C., Pruschy, M. & Vetrugno, I. Tumor hypoxia and radiotherapy: a major driver of resistance even for novel radiotherapy modalities. Semin. Cancer Biol. 98, 19\u201330 (2024).","journal-title":"Semin. Cancer Biol."},{"key":"3064_CR295","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-008591","volume":"12","author":"K Fletcher","year":"2024","unstructured":"Fletcher, K. & Johnson, D. B. Chronic immune-related adverse events arising from immune checkpoint inhibitors: an update. J. Immunother. Cancer 12, e008591 (2024).","journal-title":"J. Immunother. Cancer"},{"key":"3064_CR296","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41416-019-0526-2","volume":"121","author":"J Taieb","year":"2019","unstructured":"Taieb, J., Lapeyre-Prost, A., Laurent Puig, P. & Zaanan, A. Exploring the best treatment options for BRAF-mutant metastatic colon cancer. Br. J. Cancer 121, 434\u2013442 (2019).","journal-title":"Br. J. Cancer"},{"key":"3064_CR297","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2024.114290","volume":"210","author":"M Ambrosini","year":"2024","unstructured":"Ambrosini, M. et al. BRAF + EGFR +\/- MEK inhibitors after immune checkpoint inhibitors in BRAF V600E mutated and deficient mismatch repair or microsatellite instability high metastatic colorectal cancer. Eur. J. Cancer 210, 114290 (2024).","journal-title":"Eur. J. Cancer"},{"key":"3064_CR298","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49673-4","volume":"15","author":"C Zhong","year":"2024","unstructured":"Zhong, C. et al. CRISPR screens reveal convergent targeting strategies against evolutionarily distinct chemoresistance in cancer. Nat. Commun. 15, 5502 (2024).","journal-title":"Nat. Commun."},{"key":"3064_CR299","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1158\/2159-8290.CD-24-0740","volume":"14","author":"A Singhal","year":"2024","unstructured":"Singhal, A. et al. A classical epithelial state drives acute resistance to KRAS inhibition in pancreatic cancer. Cancer Discov. 14, 2122\u20132134 (2024).","journal-title":"Cancer Discov."},{"key":"3064_CR300","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1158\/2159-8290.CD-24-0991","volume":"15","author":"MB Hugaboom","year":"2025","unstructured":"Hugaboom, M. B. et al. Presence of tertiary lymphoid structures and exhausted tissue-resident T cells determines clinical response to PD-1 blockade in renal cell carcinoma. Cancer Discov. 15, 948\u2013968 (2025).","journal-title":"Cancer Discov."},{"key":"3064_CR301","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1038\/s41586-024-08426-5","volume":"638","author":"M Amisaki","year":"2025","unstructured":"Amisaki, M. et al. IL-33-activated ILC2s induce tertiary lymphoid structures in pancreatic cancer. Nature 638, 1076\u20131084 (2025).","journal-title":"Nature"},{"key":"3064_CR302","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1158\/2326-6066.CIR-20-0499","volume":"9","author":"IL Gomes-Santos","year":"2021","unstructured":"Gomes-Santos, I. L. et al. Exercise training improves tumor control by increasing CD8(+) T-cell infiltration via CXCR3 signaling and sensitizes breast cancer to immune checkpoint blockade. Cancer Immunol. Res. 9, 765\u2013778 (2021).","journal-title":"Cancer Immunol. Res."},{"key":"3064_CR303","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1126\/science.aao3290","volume":"359","author":"V Matson","year":"2018","unstructured":"Matson, V. et al. The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients. Science 359, 104\u2013108 (2018).","journal-title":"Science"},{"key":"3064_CR304","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00060-22","volume":"37","author":"A Yadegar","year":"2024","unstructured":"Yadegar, A. et al. Fecal microbiota transplantation: current challenges and future landscapes. Clin. Microbiol. Rev. 37, e0006022 (2024).","journal-title":"Clin. Microbiol. Rev."},{"key":"3064_CR305","doi-asserted-by":"publisher","first-page":"102315","DOI":"10.1016\/j.eclinm.2023.102315","volume":"66","author":"W Zhao","year":"2023","unstructured":"Zhao, W. et al. Fecal microbiota transplantation plus tislelizumab and fruquintinib in refractory microsatellite stable metastatic colorectal cancer: an open-label, single-arm, phase II trial (RENMIN-215). EClinicalMedicine 66, 102315 (2023).","journal-title":"EClinicalMedicine"},{"key":"3064_CR306","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1038\/s41591-023-02453-x","volume":"29","author":"B Routy","year":"2023","unstructured":"Routy, B. et al. Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial. Nat. Med. 29, 2121\u20132132 (2023).","journal-title":"Nat. Med."},{"key":"3064_CR307","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/s41392-023-01480-x","volume":"8","author":"J Yang","year":"2023","unstructured":"Yang, J. et al. Epigenetic regulation in the tumor microenvironment: molecular mechanisms and therapeutic targets. Signal Transduct. Target Ther. 8, 210 (2023).","journal-title":"Signal Transduct. Target Ther."},{"key":"3064_CR308","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1016\/S1470-2045(22)00632-5","volume":"23","author":"L Del Mastro","year":"2022","unstructured":"Del Mastro, L. et al. Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial. Lancet Oncol. 23, 1571\u20131582 (2022).","journal-title":"Lancet Oncol."},{"key":"3064_CR309","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1093\/neuonc\/noaa240","volume":"23","author":"MR Gilbert","year":"2021","unstructured":"Gilbert, M. R. et al. A phase II study of dose-dense temozolomide and lapatinib for recurrent low-grade and anaplastic supratentorial, infratentorial, and spinal cord ependymoma. Neuro Oncol. 23, 468\u2013477 (2021).","journal-title":"Neuro Oncol."},{"key":"3064_CR310","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1200\/JCO.21.02051","volume":"40","author":"C Pfister","year":"2022","unstructured":"Pfister, C. et al. Dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin or gemcitabine and cisplatin as perioperative chemotherapy for patients with nonmetastatic muscle-invasive bladder cancer: results of the GETUG-AFU V05 VESPER Trial. J. Clin. Oncol. 40, 2013\u20132022 (2022).","journal-title":"J. Clin. Oncol."},{"key":"3064_CR311","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1126\/science.1241328","volume":"343","author":"DA Nathanson","year":"2014","unstructured":"Nathanson, D. A. et al. Targeted therapy resistance mediated by dynamic regulation of extrachromosomal mutant EGFR DNA. Science 343, 72\u201376 (2014).","journal-title":"Science"},{"key":"3064_CR312","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01921-9","volume":"23","author":"H Alkhatib","year":"2024","unstructured":"Alkhatib, H. et al. Patient-specific signaling signatures predict optimal therapeutic combinations for triple negative breast cancer. Mol. Cancer 23, 17 (2024).","journal-title":"Mol. Cancer"},{"key":"3064_CR313","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.169105","volume":"10","author":"K Wittenzellner","year":"2025","unstructured":"Wittenzellner, K. et al. Label-free single-cell phenotyping to determine tumor cell heterogeneity in pancreatic cancer in real time. JCI Insight 10, e169105 (2025).","journal-title":"JCI Insight"},{"key":"3064_CR314","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/s41746-025-01978-4","volume":"8","author":"Y Zhang","year":"2025","unstructured":"Zhang, Y. et al. Digital twin models for predicting venetoclax and azacitidine-induced neutropenia in patients with acute myeloid leukemia. NPJ Digit. Med. 8, 596 (2025).","journal-title":"NPJ Digit. Med."},{"key":"3064_CR315","doi-asserted-by":"publisher","first-page":"100864","DOI":"10.1016\/j.landig.2025.02.004","volume":"7","author":"C Sad\u00e9e","year":"2025","unstructured":"Sad\u00e9e, C. et al. Medical digital twins: enabling precision medicine and medical artificial intelligence. Lancet Digit. Health 7, 100864 (2025).","journal-title":"Lancet Digit. Health"},{"key":"3064_CR316","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41586-021-03634-9","volume":"596","author":"A Rao","year":"2021","unstructured":"Rao, A., Barkley, D., Fran\u00e7a, G. S. & Yanai, I. Exploring tissue architecture using spatial transcriptomics. Nature 596, 211\u2013220 (2021).","journal-title":"Nature"},{"key":"3064_CR317","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.ccell.2025.03.004","volume":"43","author":"Y Liu","year":"2025","unstructured":"Liu, Y. et al. Conserved spatial subtypes and cellular neighborhoods of cancer-associated fibroblasts revealed by single-cell spatial multi-omics. Cancer Cell 43, 905\u2013924.e906 (2025).","journal-title":"Cancer Cell"},{"key":"3064_CR318","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.molmed.2025.01.014","volume":"31","author":"SD Robinson","year":"2025","unstructured":"Robinson, S. D. et al. Spatial biology\u2014unravelling complexity within the glioblastoma microenvironment. Trends Mol. Med. 31, 846\u2013859 (2025).","journal-title":"Trends Mol. Med."},{"key":"3064_CR319","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2025.115757","volume":"229","author":"C Chen","year":"2026","unstructured":"Chen, C. et al. Engineering tumor spatial heterogeneity in vitro. Adv. Drug Deliv. Rev. 229, 115757 (2026).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"3064_CR320","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.cell.2025.11.016","volume":"189","author":"JMJ Valanarasu","year":"2026","unstructured":"Valanarasu, J. M. J. et al. Multimodal AI generates virtual population for tumor microenvironment modeling. Cell 189, 386\u2013400.e319 (2026).","journal-title":"Cell"}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-03064-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-03064-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-03064-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:04:58Z","timestamp":1790172298000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-03064-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"references-count":320,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3064"],"URL":"https:\/\/doi.org\/10.1038\/s41392-026-03064-x","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]},"assertion":[{"value":"18 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"402"}}